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ASSEMBLY AND DISPLAY OF SURFACE PROTEINS
IN ACTINOMYCES ORIS

Sara Danielle Siegel, B.S.

Advisory Professor: Hung Ton-That, Ph.D.

Bacteria are an integral part of human health and disease. In the human host,
dental plaques form as a result of up to 700 individual bacterial species colonizing oral
surfaces and forming a multispecies biofilm. These biofilms are the cause of prevalent
human diseases such as dental caries, gingivitis, and periodontitis. The microbes
present in the oral biofilm are highly spatially and temporally structured and require a
primary colonizing species to adhere to host tissue. As an important primary colonizer of
the oral biofilm, the actinobacterium Actinomyces oris utilizes cell wall anchored proteins
and glycoconjugates to initiate adherence to host surfaces, recruit additional bacterial
species that could not bind otherwise, and maintain the structural integrity of the oral
biofilm. In this thesis, I reveal mechanisms involved in the assembly and display of
surface proteins that are central to these processes in A. oris.
Cell wall-anchored proteins contain a signal peptide to direct their secretion to
the exoplasmic side of the membrane, where they are liberated from the secretion
machine by signal peptidases. Cell wall-anchored proteins also contain a cell wall sorting
signal, which is required for their covalent attachment to peptidoglycan by
transpeptidase enzymes called sortases. Furthermore, a subset of cell wall-anchored
proteins are polymerized to form pili prior to being anchored. I found that pilin proteins
v

require a distinct signal peptidase for their maturation and function and uncovered
residues required for adherence in a minor pilin protein. In certain cases after
translocation, proteins are modified by the addition of glycopolymers, and I characterized
a phosphotransferase enzyme with a novel role in protein glycosylation. These studies
contribute to the understanding of the role of A. oris as a primary colonizer in the oral
biofilm. Additionally, using A. oris as a model for general processes has led to findings
which are applicable to principles of biofilm formation, interspecies interactions,
glycoconjugate formation, and bacterial pathogenesis.
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CHAPTER I
Introduction

1

This work is, in part, adapted or reprinted from works published in 2016: Siegel SD, Liu
J, Ton-That H. (2016) Biogenesis of the Gram-positive bacterial cell envelope. Curr Opin
Microbiol. doi: 10.1016/j.mib.2016.07.015 and Siegel SD, Reardon ME, Ton-That H.
(2016) Anchoring of LPXTG-Like Proteins to the Gram-Positive Cell Wall Envelope. Curr
Top Microbiol Immunol. doi: 10.1128/EC.00083-15. I am the first author of these
publications and was responsible for preparing the original manuscript. I have
permission to reproduce any and all of this manuscript, in print or electronically, for the
purpose of my thesis in accordance with Elsevier (publisher of Current Opinion in
Microbiology) “Journal Author Rights.” https://www.elsevier.com/about/policies/copyright
and have permission to reprint Figure 1 from Springer Nature Terms and Conditions for
RightsLink Permissions Springer Customer Service Centre GmbH : Springer Nature.
Chapter “Anchoring of LPXTG-Like Proteins to the Gram-Positive Cell Wall Envelope” in
Protein and Sugar Export and Assembly in Gram-positive Bacteria by Sara D. Siegel,
Melissa E. Reardon and Hung Ton-That. © Springer International Publishing
Switzerland 2016 (2016).

The bacterial cell envelope serves as a platform for molecular interactions. The
outermost layer of the Gram-positive envelope, the cell wall, is decorated with proteins
and glycoconjugates that mediate interactions with the local environment. In this thesis, I
reveal molecular mechanisms underlying the assembly and display of proteins on the
surface of the Gram-positive actinobacterium Actinomyces oris. My work expands the
understanding of how these proteins are elaborated and their role in interaction with host
and microbes that make A. oris a major contributor to the formation of the multispecies
oral biofilm.
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Actinomyces oris and the Oral Biofilm
Dental plaques are multispecies biofilms that form on oral surfaces and consist of
up to 700 different bacterial species (1). The oral biofilm is more easily accessible than
other human-associated microbial communities and can serve as a model for biofilms
that form on non-shedding surfaces (2). Early realizations of the complexity of this
biofilm sparked a foray into understanding the species present in the biofilm, what drove
these interactions, and whether they proceeded at random or with high specificity (3).
These studies demonstrated that pairwise interactions between two species, known as
coaggregation, is a regulated process mediated by specific receptor and adhesin pairs
(4,5). Expansion of genome based research also provided extensive knowledge about
the players involved at different stages of biofilm formation (6).
From these initial works multispecies biofilm development is proposed to occur
through a stepwise process (1,2). First, primary colonizers bind a conditioned
substratum then expand and secrete exopolysaccharide (EPS) eventually forming a
microcolony. In the oral biofilm, salivary proteins deposited on the tooth surface serve as
the conditioned substratum. These initial microcolonies modify the local environment
attracting secondary colonizers to the biofilm. Growth and secretion of EPS by
secondary colonizers culminates in the formation of a mature multispecies biofilm
(1,2,7). This regulated, hierarchical accretion of bacterial species has been confirmed by
modern micron-scale biogeographical studies that show oral biofilms exhibit a high
degree of spatial structuring (8,9). A shared matrix and a variety of molecular
interactions resulting from physical attachment and soluble molecule signals maintain
the biofilm through harsh conditions and inconstant nutrient availability (10,11).
Although oral biofilms do form in healthy hosts, problems arise from overgrowth
of these complex communities and subsequent recruitment of key pathogenic species
that have been demonstrated to subvert host immunity and modulate local and systemic
3

inflammatory responses (12). Pathogenic microbes in the oral biofilm can cause a
number of infectious diseases such as dental caries, gingivitis, and periodontitis (6).
Dental diseases caused by poor oral hygiene are considered by the World Health
Organization as among the most important global oral health burdens due to their high
prevalence and impact on human health (13). There is also extensive evidence that
suggests oral bacteria contribute to systemic diseases including cardiovascular disease
and preterm birth via a systemic inflammatory response to the presence of microbial
species disseminated through the bloodstream of those with poor oral health and
hygiene (14,15).
One bacterial genus that has emerged as a key primary colonizer and a major
contributor to oral biofilm formation is Actinomyces. Actinomyces demonstrate the
unique ability to interact with the tooth, gingiva and bacterial species (16-18), are
frequently isolated from oral biofilms (19-21), and remain abundant at the basal layer as
the biofilm expands (9,22-24). Molecular analyses have uncovered drivers of
Actinomyces ability to facilitate this structural and temporal hierarchy (18,25,26). This
means that Actinomyces can maintain the oral biofilm adherence to the tooth as it
expands below the gum line. Therefore, Actinomyces acts as a support to attract
bacteria that directly release harmful molecules to damage tissue and persist in the
periodontal pocket where they would otherwise be unable to adhere and persist (9,27).
There are several species of Actinomyces associated with the oral biofilm, and of
these Actinomyces oris has been developed as a primary model (3,21). The niche of A.
oris as a primary colonizer is heavily dependent on proteins anchored to the cell wall.
Therefore, A. oris serves as an outstanding model for basic principles of cell wall
anchoring, pilus polymerization, and molecular interactions necessary for multi- and
mono-species biofilm formation. We also have defined morphological characteristics

4

(Fig. 1-1), established molecular techniques, and an arsenal of approaches to address
the physiological impact of genetic manipulations in A. oris.
The role of A. oris as a primary colonizer of the oral biofilm is associated with the
expression of two distinct pilus types (21). Actinomyces pili are among the earliest
imaged bacterial macrostructures by electron microscopy (28) and were the first sortasecatalyzed pilus operons identified by sequencing (29). Early studies in A. oris
demonstrated that these pili are accessible to immune cells, and inhibition of either type
1 or type 2 pili leads to loss of colonization (30-34). However, molecular details of the
biogenesis of these pili remained a mystery until sortase-catalyzed pili were described in
Corynebacterium diphtheriae (35), a finding that uncovered conserved mechanisms for
several Gram-positive pili including those from Actinomyces (36).
These features have established A. oris as a model to study actinobacterial
protein secretion, cell envelope biogenesis, cell wall sorting, and molecular interactions
that occur at the cell surface. Cell surface display of macromolecules begins after
proteins are translocated across the cytoplasmic membrane and may require oxidative
protein folding. Once outside of the cell, proteins can be further modified by a suite of
membrane-associated enzymes. These modifications can include cell wall anchoring by
sortase enzymes or the addition of glycopolymers. Proteins displayed on the cell surface
are accessible to the environment and contribute to modulation of cellular physiology
and interactions required for pathogenicity. And although pili are the most well described
contributors to biofilm formation, we still do not have a complete understanding of either
the players mediating additional interactions or the role of the suite of other cell wall
associated proteins.

5

Figure 1-1: Known cell surface protein dependent processes in Actinomyces oris.
A. oris are represented as purple rod-shaped cells undergoing snapping division. Each
arrow points to a physiological property that we can assess and the associated cell
surface protein(s). Specifically, these proteins are covalently attached and/or
polymerized by sortases. The colonization of teeth and gums depends on type 1 pili and
CafA-containing type 2 pili, respectively. Additionally, CafA is required to mediate
coaggregation with oral streptococci, shown here in light green. Monospecies biofilm
formation is mediated by type 2 pili, specifically FimA polymers, and EPS is represented
in the background. Maintenance of the mono- and multi-species biofilm in the presence
of salts is mediated by GspAHMM (unpublished data from Abu Amar Al Mamun, used with
permission), Na+ and K+ ions are represented with orange dots. Figure was generated
using © BioRender.
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Glycoconjugates of the Gram-positive Cell Envelope
The Gram-positive cell envelope is a broadly defined structure encompassing the
exoplasmic face of the cytoplasmic membrane and the characteristically thick layered
meshwork of peptidoglycan called the cell wall as well as all of the components
associated with these megastructures (37). The cytoplasmic membrane allows for
nutrient acquisition, embeds transporter proteins, and maintains an electrochemical
gradient important for energy production and protein transport. A thick layer of
peptidoglycan surrounds the cytoplasmic membrane. Although we tend to regard the
peptidoglycan as a static structure, new evidence suggests that there is a stunning
variety of wall-associated glycoconjugates that are variable in presence and composition
(38,39). In addition to glycoconjugates, there are also proteins covalently attached to the
cell wall (40). The combination of these cell envelope features underlies bacterial
viability, environmental interactions, and niche selection (39). Recent investigations of
the Gram-positive cell envelope have focused on the individuality of molecular
composition and how these variations in the cell envelope are derived and translated
into distinct functions and phenotypes.
A major source of variation in the cell envelope arises from envelope associated
glycoconjugates (38,39). In addition to the notably conserved glycoconjugate
peptidoglycan, there are several additional glycoconjugates that contribute to the
individuality of the bacterial cell envelope. These include the capsular polysaccharide,
exopolysaccharide, glycan-modified pili and flagella, wall and lipo-teichoic acids, and
glycoproteins.
Peptidoglycan
Peptidoglycan (PG) is the rigid bacterial glycoconjugate that provides structure
for cell morphology and protects cells from turgor pressure resulting from external
7

osmotic changes. It is the most highly conserved glycoconjugate in bacteria consisting of
N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc) sugar moieties and
a pentapeptide attached to the MurNAc subunit. It is present in all bacteria except
Mycoplasma (41). The GlcNAc-MurNAc-pentapeptide precursors are synthesized in the
cytoplasm, attached to the universal lipid carrier undecaprenol phosphate (UndP), and
flipped across the membrane. In the exoplasmic space, the precursors are accessible to
transglycosylases that link MurNAc to GlcNAc moieties to form the glycan chains.
Transpeptidase enzymes then covalently link these repeating MurNAc-GlcNAcpentapeptide units together forming a peptide crossbridge. This process is repeated until
eventually a durable mesh structure is formed (36). PG glycan chain length differs
between species, but variations of the peptidoglycan structure are introduced primarily to
the pentapeptide composition (41).
Wall teichoic acids
Wall teichoic acids (WTA) are long anionic glycopolymers that are attached to
and threaded through the PG layer. These molecules extend beyond the cell wall and
account for a significant portion of the cell mass (37,42). WTA polymers consist of
repeating polyribitol phosphate or polyglycerol phosphate subunits attached by a
phosphodiester bond to the MurNAc subunit on peptidoglycan. WTAs are negatively
charged, and their display has been implicated in several different and species specific
functions (37,39). The negative charge of the polymers gives teichoic acids the capacity
to bind cations (42). Accordingly, one of the earliest functions attributed to WTAs was a
role in cation homeostasis (43). WTAs have since been found to have a range of
functions including protection against cationic antimicrobial peptides, reduced biofilm
formation on abiotic surfaces, and resistance to lysozyme (39).
The attachment of teichoic acids to the cell wall is mediated by a family of
enzymes containing LytR-CspA-PsrA domains or LCP enzymes (44). The activity of the
8

LCP enzymes extends beyond just WTA synthesis and have been described to catalyze
the attachment of other glycopolymers to the bacterial cell wall such as arabinogalactan,
glucose-rhamnose-polymer, and capsular polysaccharides (45-48). LCP enzymes have
recently been found to protect Mycobacterium tuberculosis from LC3-associated
phagocytosis without affecting arabinogalactan display or cell wall integrity suggesting
an entirely different role for this particular LCP (49). In A. oris, the function of one LCP
enzyme, LcpA, is the transfer of an unknown glycopolymer to a cell wall anchored
protein called GspA (50). Combined, these data suggest that LCP enzymes recognize a
spectrum of substrate and acceptor molecules. The specific activity of A. oris LcpA that
is required to glycosylate GspA is investigated in chapter IV.
Glycoproteins
The function of LcpA in the glycosylation of a protein substrate came as a
surprise because it is typically accepted that bacterial proteins are either N- or Oglycosylated meaning that the glycopolymers are attached to asparagine or
serine/threonine residues, respectively. Protein glycosylation mechanisms are
distinguished by whether they proceed via sequential or en bloc glycosylation (38).
Substrates that are sequentially glycosylated are directly targeted by specific glycosyl
transferase (GTase) enzymes that transfer specific sugar molecules one at a time. In
contrast, if the glycan is fully synthesized in the cytoplasm and transferred across the
membrane on the UndP lipid carrier prior to transfer, this is en bloc glycosylation.
Oligosaccharyltransferase (OSTase) enzymes are responsible for en bloc protein
glycosylation in bacteria. Determination of all glycopolymer composition is notably
challenging because glycosylation occurs through a non-templated process and often
results in complex structure (38,39).

9

Cell Wall Anchored Proteins
The surface proteins that decorate the A. oris cell are part of the larger cell
envelope structure and are another major source of cell envelope variation (37,51).
Proteins destined for secretion contain an N-terminal signal peptide and are addressed
for cell wall anchoring via a C-terminal cell wall sorting signal. Cell wall anchored
proteins mediate many of the specific functions that require direct interactions such as
adherence.
General protein translocation machinery
The assembly of proteins on the exoplasmic side of the membrane requires the
proteins to first be secreted beyond the cytoplasmic membrane. Secreted proteins are
specifically addressed to translocation machines after being synthesized in the
cytoplasm. These addresses, or signal peptides, specify the protein for either general
secretion (Sec) or twin-arginine translocation (Tat) transport. Recognition of the signal
peptide by the secretion machine components is the first step of the translocation event.
Signal peptides are located at the N-terminus of a polypeptide and are short,
unstructured primary amino acid sequences. In Gram-positive bacteria signal peptides
are on average 30 amino acids in length (52). Signal peptides can be divided into three
distinct regions, the positively charged n-region followed by a hydrophobic domain (hregion) and a polar cleavage (c-region) containing an AXA motif, but overall have little
sequence similarity (53).
The subsequent translocation step is the most energy intensive step in the
process. The Sec and Tat pathways are the two major secretion systems in bacteria. A
major distinction between the secretion machines is the folding state required for
successful substrate translocation. The Sec protein conducting channel is narrow
allowing for only one or two polypeptide chains at a time. In contrast, the Tat system
10

secretes folded proteins through a variably sized channel appropriate for individual
substrates. These mechanism also differ in energetics. Although both require high
energy expenditure, Sec consumes NTP to translocate proteins, while Tat utilizes the
proton motive force (PMF) (54).
Proteins targeted to the Sec pathway proceed in an unfolded state. Because the
substrates are unfolded, Sec translocation can occur co- or post-translationally. Cotranslational targeting is mediated by a protein called signal recognition particle, and
post-translational polypeptides are maintained in an unfolded state by cytoplasmic
chaperones that interact with SecA at the secretion channel. The protein conducting
channel of SecYEG is a heterotrimer, which interacts with the soluble ATPase SecA to
power translocation (55).
The twin-arginine translocon signal peptide, as the name suggests, contains two
consecutive arginine residues with the conserved consensus sequence being
(S/T)RRxFLK (55). Gram-positive Tat machines have two core components, TatA and
TatC, and can include the accessory components TatB and TatE depending on the
organism (56,57). A. oris encodes tatA and tatC in a gene cluster and tatB elsewhere in
the genome. TatA is a membrane bound monomer with a cytoplasmic C-terminal
extension. TatC has six transmembrane helices with the N-terminus and C-terminus
facing into the cytoplasm (56). TatB and TatE are TatA-like proteins, and TatB has been
shown to be constitutively associated with TatC to form the TAT signal peptide
recognition complex whereas TatE has been shown to be functionally redundant to TatA.
Following signal peptide binding to the TatBC recognition complex, TatA moves laterally
through the membrane to the site of translocation and oligomerizes in a PMF dependent
manner to form a protein conducting channel matching the size of the substrate (56,58).
The terminal step of translocation regardless of whether proteins are secreted by
Sec or Tat is removal of the signal peptide so that the protein can be freed from the
11

translocation machine to fulfill its subsequent function. Non-lipoprotein signal peptide
cleavage is catalyzed by type I signal peptidases (SPase). SPases are serine
endopeptidases that recognize an AXA motif present in the signal peptide c-region and
cleave immediately after this motif leaving a mature, secreted protein (59,60). Integral
membrane proteins that do not contain a cleavage site are laterally inserted from the
secretion machine by YidC (40,61). A type I SPase from A. oris with novel substrate
specificity is analyzed in chapter III.
Oxidative protein folding
Proteins secreted via the Sec translocon often contain cysteine residues that
participate in a disulfide bond. Due to the lack of a traditional periplasm, disulfide bond
(DSB) formation in Gram-positive bacteria was considered to be only a specialized
phenomenon with a paired substrate-enzyme. However, recent in vivo analysis of a
disulfide bond forming pathways revealed the physiological importance of DSB formation
in the biogenesis of the actinobacterial cell envelope (62,63).
The major complex required for oxidative protein folding in A. oris consists of two
proteins, the main oxidoreductase MdbA and its reoxidizing partner protein VKOR
(62,64). As secreted proteins exit the translocation machine, MdbA catalyzes the
formation of consecutive disulfide bonds. In the absence of MdbA or if participating
cysteines are mutated so that they can no longer form a disulfide bond, many proteins
including actinobacterial pili and toxins, lose stability and become degraded or remain
nonfunctional (25,62,65). Additionally, in the absence of the reoxidizing factor VKOR,
protein stability is compromised, although not to the extent of the MdbA deletion (64).
Cell wall sorting pathway
Proteins which are secreted and contain a cell wall sorting signal (CWS) are
covalently attached to the cell wall by a transpeptidase enzyme called sortase. Thus far,
12

all known cell wall anchored proteins proceed through the Sec pathway (40). The CWS
is a tripartite signal containing an LPXTG motif followed by a hydrophobic domain and a
positively charged tail (51). After secretion, CWS containing proteins are retained in the
membrane by the hydrophobic domain of the CWS. Within the CWS is a conserved motif
of five residues referred to as the LPXTG motif (66). Sortase recognizes the CWS to
anchor the protein to the cell wall (40). During the anchoring reaction, the LPXTG
residues interact with the sortase catalytic pocket, which is necessary for the formation
of a sortase-substrate acyl intermediate (67). This intermediate is then resolved by a
nucleophilic attack of the free amine group from the lipid II precursor, then incorporated
into the cell wall (Fig. 1-2A). Cell wall sorting allows for the attachment of both
monomeric and polymeric proteins to the cell wall (Fig. 1-2B and C). Using immunogold
labeling and electron microscopy (IEM) monomeric and polymeric cell wall proteins can
be visualized and have a distinctive pattern. Here, monomeric cell wall anchored
proteins are represented by GspA (Fig. 1-2B) and polymeric proteins are represented by
the type 2 pilin backbone FimA (Fig. 1-2C).
All Gram-positive bacteria sequenced thus far encode at least one sortase (68).
Based on primary amino acid sequence homology and substrate preference, six sortase
classes have been proposed, known as class A – F (66). Sortases can have a broad
substrate range as is the case of housekeeping sortases, or in the case of pilin-specific
sortases recognize single or few substrates with high specificity. Housekeeping sortases
from firmicutes exemplify the Class A sortases that recognize the canonical LPXTG motif
and include SrtA from S. aureus. Actinobacterial housekeeping sortases fall into Class E
and recognize an LAXTG motif (66). Class C sortases are those that are uniquely
responsible for pilus polymerization (35,66). Class B sortases have a role in anchoring
iron-regulated proteins, class D sortases are related to sporulation and class F sortases
have an unknown function (66).
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Figure 1-2. Sortase anchors monomeric and polymeric substrates to the cell wall.
(A) Schematic depicting cell wall anchoring pathway for the paradigm housekeeping
sortase SrtA from S. aureus. Cell wall anchored proteins are first exported to the
exoplasmic side of the membrane by their N-terminal signal peptide (1). Then, a signal
peptidase cleaves off the signal peptide so that the protein can fold (2). The cell wall
anchored protein precursor is retained in the membrane by the hydrophobic domain of
the C-terminal cell wall sorting signal (CWSS) (3). Sortase recognizes the CWSS and
cleaves between the threonine and glycine residues of the LPXTG motif forming an acyl
intermediate with the substrate (AI). The sortase-substrate intermediate is resolved by
the free amino group of the glycine crossbridge on the lipid II precursor (P3) and is
incorporated into the cell wall via normal cell wall building processes (4). Permission to
reprint Figure 1 from Springer Nature Terms and Conditions for RightsLink Permissions
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Springer Customer Service Centre GmbH : Springer Nature. Chapter “Anchoring of
LPXTG-Like Proteins to the Gram-Positive Cell Wall Envelope” in Protein and Sugar
Export and Assembly in Gram-positive Bacteria by Sara D. Siegel, Melissa E. Reardon
and Hung Ton-That. © Springer International Publishing Switzerland 2016 (2016). (B)
Monomeric cell wall anchored protein, GspA. (C) Polymeric cell wall anchored protein,
FimA. For B and C, the proteins were reacted with a specific primary antibody and then
treated with a secondary antibody conjugated to a 12-nm gold particle and viewed by
electron microscopy. Scale bar represents 0.2 nm.
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Sortase-Catalyzed Pilus Assembly
Utilizing Class C sortases, Gram-positive bacteria elaborate covalently linked
polymeric proteins called pili or fimbriae (Fig. 1-2C). These structures are strongly
associated with pathogenicity and play a direct role in bacterial adherence (35,69-74).
Pilin subunits are covalently linked by pilin specific sortases and to the cell wall by the
housekeeping sortase enzyme. Individual pilin subunits have an isopeptide bond in the
Cna domain that contribute to overall stability of the subunits and polymer (25,75,76).
The Cna domain superfamily was first defined in an S. aureus collagen binding protein, it
forms a stalk-like fold that present the ligand binding domains in a variety of cell and
pilus-associated adhesin proteins (77). By measuring the amount of mechanical force
that could be applied to a pilus by atomic force microscopy, A. oris type 2 pili have been
demonstrated to withstand forces of approximately 690 pN, owing largely to the
isopeptide bond (76,78). These forces are the strongest reported for globular proteins
and likely contribute to the ability to withstand large mechanical disturbances that exist in
the A. oris niche (78).
A. oris pili are heterodimeric polymers made of a repeating major pilin subunits,
FimP or FimA, and a single minor pilin tip protein. Pilin-specific sortases are typically
genetically clustered with the pilin subunits they polymerize and have high specificity for
their substrates. For example, A. oris encodes SrtC1 and SrtC2, which polymerize type 1
and type 2 pili, respectively. Type 1 pili are encoded by the fimQ-fimP-srtC1 cluster (18).
Type 2 pili are encoded by fimB-fimA-srtC2 (29,79). An interesting exception is the
alternative tip protein CafA, which is encoded outside of the type 2 gene cluster (Fig. 13A), but is polymerized by SrtC2 with the major pilin subunit FimA (Fig. 1-3B) (25). CafA
is a pilus-associated adhesin that plays a major role the ability of A. oris to colonize the
oral biofilm. CafA mediates both coaggregation with oral streptococci, and adherence to
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host tissues. Studies of the molecular requirements for CafA binding are described in
chapter V.
Cognate pilin-specific sortase recognizes the LPXTG motif in the membrane
retained pilin precursors and cleaves between the threonine (T) and glycine (G) residues
to form a sortase-pilin acyl intermediate. Polymerization occurs when the intermediate is
resolved by a nucleophilic attack from a lysine (K) group of the major pilin subunit (35).
Pili are anchored to the cell wall by a free amine group from the lipid II cell wall precursor
(Fig. 1-3B) (40).
In A. oris, SrtC1 and SrtC2 require a tip protein to initiate polymerization. Thus,
substrate entry and polymerization steps seem to be regulated (18,25). However, the
regulation and molecular requirements for initiation and specificity are not fully
understood. A feature that is conserved among the pilus tip proteins is the presence of a
putative Tat signal peptide. The possible involvement of the Tat translocation system in
CafA export is explored in chapter VI.
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Figure 1-3: Type 2 pili are polymerized by the pilus-specific sortase SrtC2. (A) The
type 2 pilus gene cluster encoding fimB-fimA-srtC2. cafA and srtA are positioned outside
of the gene cluster, but are also involved in assembly of type 2 pili. (B) Graphic
representation of the type 2 pilus polymerization pathway in A. oris. Pilin precursors are
secreted via a signal peptide then retained in the membrane by the cell wall sorting
signal (CWS). The type 2 pilus-specific sortase SrtC2 forms an acyl intermediate with
the pilin precursors, as described above. A minor tip pilin, either FimB or CafA, initiates
polymerization of the major pilin subunit FimA. Once a minor-major pilin heterodimer is
formed the major pilin subunit is polymerized successively until the housekeeping
sortase SrtA catalyzes cell wall anchoring.
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Significance of these Studies
Oral biofilm-associated diseases are significant global oral health burdens,
however, there is no effective therapy to control oral biofilms (13). A. oris plays a critical
role in development of the oral biofilm as a primary colonizer enriched at the base of the
biofilm and facilitates the adherence of species that cannot bind otherwise (8,9). The
studies in this thesis investigate protein and glycan assembly and display on the A. oris
cell envelope and their roles in oral biofilm formation.
Proteins displayed on the surface must be translocated before surface
attachment. The final step of translocation is cleavage of the signal peptide as the
protein emerges from the secretion machinery. I have shown that a type SPase LepB2 is
required for pilus assembly, but dispensable for other cell wall anchored proteins. The
deletion of LepB2 also decreases biofilm formation and coaggregation, which are
physiologically relevant phenotypes (80). Importantly, the second signal peptidase
encoded by A. oris LepB1 is not involved in these processes. While the presence of
multiple signal peptidases is not uncommon in Gram-positive bacteria, the specific role
and target specificity of these homologous enzymes is often unknown (55). This system
provides a new model containing only two non-redundant SPase I enzymes with known
substrate specificity.
After translocation, proteins on the surface can be modified by en bloc
glycosylation. The cell wall anchored protein GspA is glycosylated in an LcpAdependent manner (50). This represents an entirely new mode of protein glycosylation
(81), because LCP enzymes have been shown to catalyze the transfer of glycopolymers
to the cell wall, but had not been previously demonstrated to modify protein substrates. I
have characterized the residues and activities of LcpA that are required for this novel
functionality. My work revealed that the A. oris LcpA has phosphotransferase activity
similar to other LCP enzymes, and our results are applicable for a broad range of LCP
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enzymes. This system can be used to address how LCP enzymes select acceptor
substrates.
Once proteins on the cell surface are fully translocated, modified, and anchored,
they can contribute to adherence, a critical factor contributing to bacterial pathogenesis. I
have investigated how a pilus-associated adhesin, CafA, contributes to oral biofilm
formation in two distinct ways by adhering to both oral streptococci and human gingival
cells. This study also addressed the prevalence and conservation of CafA among
different A. oris strains. These studies can be extended to other bacterial adhesins, and
enhance our overall understanding of adhesins in formation of multispecies biofilms.
I have also examined the role of a putative twin arginine signal peptide in CafA
secretion. This work has shown that there are likely additional factors contributing to the
secretion of proteins through either Sec or Tat. Bioinformatics predicted the presence of
a Tat signal peptide in CafA. However, our mutagenesis studies suggested that the twin
arginine residues were required for stability, but could not mediate secretion of two Tatdependent reporter proteins.
Overall, my studies have explored how cell surface proteins are successfully
translocated, glycosylated, and contribute to biofilm formation in the oral microbe
Actinomyces oris. My work has established new possibilities for investigating signal
peptidase specificity, LCP-mediated protein glycosylation, protein adherence function,
and tools for the Tat pathway.
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CHAPTER II
Materials and Methods
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This chapter is based, in part, upon work published in 2016: Siegel SD, Wu C, Ton-That
H “A type I signal peptidase is required for pilus assembly in the Gram-positive biofilmforming bacterium Actinomyces oris.” J Bact. 198(15):2064-73. doi: 10.1128/JB.0035316. I am the first author of this publication and was responsible for preparing the original
manuscript and conducting the experiments described in this paper. I have permission to
reproduce any and all of this manuscript, in print or electronically, for the purpose of my
thesis in accordance with the American Society for Microbiology (publisher of Journal of
Bacteriology) “Journals Statements of Authors’ Rights.”
http://journals.asm.org/site/misc/ASM_Author_Statement.xhtml.

Bacterial strains and media. Actinomyces strains were grown in heart infusion broth
(HIB) and on heart infusion agar (HIA) supplemented with 0.5% glucose at 37°C with 5%
CO2. Streptococcus strains were grown in HIB and on HIA supplemented with 1.0%
glucose at 37°C in anaerobic conditions. E. coli strains were grown in Luria broth (LB) or
Luria agar (LA) at 37°C in aerobic conditions. When appropriate, 50 µg mL-1 kanamycin
(Kan) or streptomycin (Sm) or 100 ug mL-1 of ampicillin (Amp) was added to the media.
E. coli DH5α was used for cloning experiments. Restriction enzymes, T4 polynucleotide
kinase, LIC-qualified T4 DNA polymerase, T4 DNA ligase and Phusion DNA polymerase
were purchased from New England Biolabs. A list of strains can be found in Table 2-1.
Human cell culture. Human gingival fibroblast (HGF-1) cells (ATCC® CRL-2014™)
were grown in Dulbecco’s Modified Eagle’s Medium (DMEM) with 10% heat-inactivated
fetal bovine serum and 1% penicillin/streptomycin at 37°C with 5% CO2, with medium
renewal every three days. To subculture, the medium was removed and treated with 1mL 0.25% trypsin, 0.53 mM EDTA (TE) at 37°C for 10 minutes, until the cells detached
from the flask. Cells in suspension were pelleted by centrifugation, and the supernatant
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containing TE was aspirated. The cells were sub-cultured at a 1:4 ratio and new media
was added.
E. coli competent cells and heat shock transformation. E. coli cells were subcultured
from overnight cultures in LB and grown until ODA600 = 0.6. The cells were chilled for 10
minutes (min), then centrifuged in a pre-chilled 4°C rotor at 6,000 rpm for 5 min. The
supernatant was discarded and the pellet was suspended in 20 mL TfbI (30 mM
KCH3CO2, 100 mM RbCl, 10 mM CaCl2, 50 mM MnCl, pH 5.8) then chilled on ice for 5
mins before pelleting by centrifugation. The cell pellets were then suspended in 2 mL
TfbII (10 mM PIPES, 10 mM RbCl, 75 mM CaCl, 15% v/v glycerol, pH 6.5) and chilled on
ice for 15 mins. Then, 100 µL cells were then aliquoted into sterile, pre-chilled 1.5 mL
tubes and snap frozen in a dry ice ethanol bath. The aliquots were stored at -80°C. To
transform the competent cells, an aliquot of competent cells was thawed on ice for 10
mins. Then, 100 ng of plasmid was added to the cells for 1 hour followed by heat shock
at 42°C for 40 seconds. Cells were recovered in LB for 20 mins at 37°C with shaking,
then plated on LA with Amp.
A. oris competent cells and electroporation. Overnight A. oris cells were subcultured
into 25 mL HIB, and grown at 37°C to an ODA600 = 0.6. 10% glycine in HIB was added
and the cells were incubated for an additional hour. Cells were chilled on ice for 20 mins
then centrifuged at 6,000 rpm for 10 min at 4°C. The cells were washed twice with cold
15% glycerol and finally suspended in 1.5 mL 15% glycerol before aliquoting 100 µL into
1.5 mL tubes, snap frozen (as above) and stored at -80°C. To transform the A. oris cells,
plasmid was added to a thawed competent cell aliquot, swirled to mix and transferred to
a 2 mm gap electroporation cuvette (Sigma). The cells were electroporated at 2,500 V
with 25 µF capacitance and 400 Ω of resistance (82). HIB was added to the cuvette
immediately following electroporation and recovered for 2 hours at 37°C before plating
onto HIA containing either Kan or Sm.
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Table 2-1. Bacterial strains and cell lines used in this studies
Strain
E. coli DH5α

Description
Plasmid propagation and cloning strain

Reference
(83)

A. oris MG1

Parental strain

(84)

A. oris CW1

∆galK; an isogenic derivative of MG-1

(79)

S. oralis So34

RPS positive

(85)

S. oralis OC1
A. oris AR4
A.oris WU36

(85)
(79)
(50)

A. naeslundii N28B15

RPS-negative isogenic mutant of So34
∆fimA; an isogenic derivative of CW1
Conditional srtA deletion mutant (∆srtA),
containing pTetR--SrtA
∆gspA; an isogenic derivative of CW1
∆gspA/∆srtA
∆lepB2; an isogenic derivative of CW1
∆lepB1; an isogenic derivative of CW1
∆lepB1/2; an isogenic derivative of CW1
∆lepB2/∆srtA
WU42 containing pLepB2
WU42 containing pLepB2(S101A)
WU42 containing pLepB2(K169A)
∆lcpA; an isogenic derivative of CW1
∆lcpB; an isogenic derivative of CW1
∆lcpD; an isogenic derivative of CW1
∆lcpA∆lcpB∆lcpD
∆vkor; an isogenic derivative of CW1
Derived from E. coli K12 parental strains,
engineered to form disulfide bonds in the
cytoplasm; expresses T7 RNAP.
∆cafA; an isogenic derivative of CW1
Conditional srtA deletion mutant, inducible by
addition of tetracycline and theophylline
Clinical isolate

A. naeslundii N34A24

Clinical isolate

J. Cisar collection

A. naeslundii N35B3

Clinical isolate

J. Cisar collection

A. oris N11A16

Clinical isolate

J. Cisar collection

A. oris N12A2B

Clinical isolate

J. Cisar collection

A. oris ATCC®
49339™
A. oris N11A12

Human abscess isolate

J. Cisar collection

Clinical isolate

J. Cisar collection

A. oris ATCC®
27044™

Human sputum isolate

J. Cisar collection

A.oris WU51
A.oris WU73
A.oris WU42
A.oris WU50
A.oris WU80
A.oris WU81
A.oris WU42c1
A.oris WU42c2
A.oris WU42c3
A. oris WU72
A. oris D0299
A. oris D1578
A. oris lcp∆3
A. oris MR108
E. coli C3209/
Shuffle®
A. oris AR5
A. oris tetR--tatC

(50)
(50)
(80)
(80)
(80)
(80)
(80)
(80)
(80)
(50)
This study
This study
This study
(62)
(86)

(25)
This study
J. Cisar collection
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A. oris N33A2B

Clinical isolate

J. Cisar collection

A. oris N37B13

Clinical isolate

J. Cisar collection

A. oris N34A23

Clinical isolate

J. Cisar collection

A. oris N28B1

Clinical isolate

J. Cisar collection

A. oris N29A27

Clinical isolate

J. Cisar collection

A. oris N32A8

Clinical isolate

J. Cisar collection

A. oris N37B9

Clinical isolate

J. Cisar collection

Actinomyces n/sa
N38B10
Actinomyces n/s
N33A3
Actinomyces n/s
N34A14

Clinical isolate

J. Cisar collection

Clinical isolate

J. Cisar collection

Clinical isolate

J. Cisar collection

A. johnsonii PK1259

Clinical isolate

J. Cisar collection

A. johnsonii ATCC®
49338™

Human gingival crevice isolate

J. Cisar collection

Streptomyces
violaceoruber M145

Prototrophic derivative of S. coelicolor A3(2)

ATCC® BAA-471™

HGF-1

Human gingival fibroblast cell line (ATCC® CRL2014™)

ATCC

non-serotypable
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Plasmid construction
A list of plasmids can be found in Table 2-2 and list of primers in Table 2-3.
pCWU10 – To generate a RSF1010 derivative that is functional in A. oris, the
ampicillin resistance gene of pCVD047, a cyanobacterial broad-host-range vector (87),
was replaced by the kanamycin (kan) cassette from pJRD215 (88). Briefly, using the
primer pair pCVD047-noAmp-F/R for an inverse PCR reaction, an amplicon containing
pCVD047 sequence without the ampicillin resistance gene was generated. Next, the
fragment encompassing the kan resistance gene and a multiple cloning site from
pJRD215 was amplified with the primer pair 215KanMCS-F/R. Both amplicons were
digested with SacI and HindIII. The isolated products were ligated to generate pCWU10.
pGspAΔcwss – Using pAcaCΔcws (50) as a template, primers com-AcaC-F and
GspA∆cws-His6-R were used to PCR-amplify a fragment encompassing the promoter
region of gspA and its open reading frame (ORF) lacking the cell wall sorting signal
(CWS) while appending a hexa-histidine tag to the GspA C-terminus. The gspA
amplicon was digested with NdeI and EcoRI and ligated into pCWU10 digested with the
same enzymes to generate pGspAΔcwss.
pFimAΔcwss – The primer sets prFimB-BamHI-F and prFimB-R and FimA-F and
FimA∆cws-His6-EcoRI-R were used in PCR reactions with MG1 genomic DNA as a
template to amplify the promoter region of fimB and the fimA ORF lacking the CWSS
while appending a hexa-histidine tag to the FimA C-terminus, respectively. The fimB
promoter product was digested with BamHI whereas the fimA coding region was
digested with EcoRI and then treated with T4 polynucleotide kinase to phosphorylate the
5’ end. The digested DNA fragments were ligated into pCWU10 digested with BamHI
and EcoR1 to generate pFimA∆cwss.
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pCWu2-∆lepB1 – 1 kb upstream and downstream the lepB1 (ana_1188) open
reading frame was amplified using primer pairs 1188up-F and 1188up-R and 1188dn-F
and 1188dn-R. 1188up fragment was engineered with a 5’ EcoRI and 3’ XbaI restriction
site and the 1188dn fragment was engineered with 5’ XbaI and 3’ KpnI restriction sites to
facilitate ligation of the fragments to the pCWu2 vector digested with EcoRI and KpnI, in
the presence of T4 DNA ligase.
pCWu2-∆lepB2 – 1 kb upstream and downstream the lepB2 (ana_1190) open
reading frame was amplified using primer pairs 1190up-F and 1190up-R and 1190dn-F
and 1190dn-R. 1190up fragment was engineered with a 5’ XbaI and 3’ HindIII restriction
site, and the 1190dn fragment was engineered with 5’ HindIII and 3’ EcoRI restriction
sites to facilitate ligation of the fragments to the pCWu2 vector digested with XbaI and
EcoRI, in the presence of T4 DNA ligase.
pLepB2 – The lepB2 coding sequence and rimM promoter region were amplified
from pLepB2 with the primers Pro-1192-F and com-lepB2-R. The PCR product was
digested by EcoRI and HindIII and ligated into pJRD215 (84) digested with the same
enzymes.
prGspA – gspA (ana_1291) sequence containing only residues 31 and 256
(lacking signal peptide and cell wall sorting signal) was amplified from the A. oris MG1
genomic DNA template with the primers rGspA-F and rGspA-R, containing adapter
sequences for subsequent ligation independent cloning (LIC) into pMCSG7. The
resultant amplicons were treated with LIC-qualified T4 DNA polymerase and dCTP. In
parallel, the SspI digested vector was treated with T4 DNA polymerase and dGTP. The
insert and vector fragments were ligated in a step-down annealing reaction. The vector
was transformed into chemically competent E. coli DH5α.
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pLcpA – LcpA (ana_1292) complement strain was cloned by amplifying the
native promoter, 152 bp upstream of the start codon until the native stop codon using
primers pLCP-F and pLCP-R engineered with a BamHI and EcoRI cut site respectively
and using A. oris MG1 genomic DNA as a template. The resultant amplicon was gel
purified. Simultaneous restriction digest with BamHI-HF and EcoRI-HF of the amplicon
and parental plasmid (pCWu10) was performed, and the products were again gel
purified. The restricted products were ligated with T4 DNA ligase at 16°C for 18 h. The
ligation mixture was transformed into chemically competent E. coli DH5α, and colony
PCR was used to identify plasmids with the correct insert. The plasmid was introduced
to A. oris ∆lcpA cells via electroporation (88).
pCWu2-∆lcpB – 1 kb upstream and downstream the lcpB (ana_0299) open
reading frame was amplified using primer pairs 0299up-F and 0299up-R and 0299dn-F
and 0299dn-R. 0299up fragment was engineered with a 5’ KpnI and 3’ XbaI restriction
site, and the 0299dn fragment was engineered with 5’ XbaI and 3’ EcoRI restriction site
to facilitate ligation of the fragments to the pCWu2 vector digested with KpnI and EcoRI
in the presence of T4 DNA ligase.
pCWu2-∆lcpD – 1 kb upstream and downstream the lcpD (ana_1578) open
reading frame was amplified using primer pairs 1578up-F and 1578up-R and 1578dn-F
and 1578dn-R. 1578up fragment was engineered with a 5’ KpnI and 3’ XbaI restriction
site, and the 1578dn fragment was engineered with a 5’ XbaI and 3’ EcoRI restriction
site to facilitate ligation of the fragments to the pCWu2 vector digested with KpnI and
EcoRI in the presence of T4 DNA ligase.
rLcpA – lcpA (ana_1292) sequence containing residues 78 and 370 (lacking the
transmembrane region) was amplified from the A. oris MG1 genomic DNA template with
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the primers rLcpA-F and LCP∆TM-R containing adapter sequences for subsequent
ligation independent cloning (LIC) into pMCSG7 (89).
pCafA – The A. oris MG1 CafA (ana_2235) complement strain was cloned by
amplifying the native promoter, 407 bp upstream of the start codon until the native stop
codon, using primers CafA-pro-F and CafA_comp-R engineered with a KpnI and BamHI
cut site respectively and using A. oris MG1 genomic DNA (gDNA) as a template. The
resultant amplicon was gel purified. The amplicon and parental plasmid (pCWu10) were
simultaneously digested with the restriction enzymes KpnI-HF and BamHI-HF, and the
products were purified. The restricted products were ligated with T4 DNA ligase at 16°C
for 18 hours.
pCafA∆cws-H6 – The CafA (ana_2235) native purification strain was cloned by
amplifying the native promoter, 407 bp upstream of the start codon until the CWS, using
primers CafA_pro-F and CafA∆cws-H6-R engineered with a KpnI and hexa-histidineBamHI cut site respectively and using A. oris MG1 pCafA as a template. The resultant
amplicon was gel purified. The amplicon and parental plasmid (pCWu10) were
simultaneously digested with the restriction enzymes KpnI-HF and BamHI-HF (NEB),
and the products were purified. The restricted products were ligated with T4 DNA ligase
at 16°C for 18 hours.
pGFP – Green fluorescent protein (GFP) was amplified from pBsk-GFP using
primers GFP-F and GFP-R. To drive expression, the EF-Tu (ana_0022) promoter was
cloned upstream of GFP using the primers prom-EF-tu-F and prom-EF-tu-R. To facilitate
ligation, prom-EF-tu-F was designed with a KpnI restriction site and GFP-R was
designed with a BamHI restriction site. The GFP fragment was treated with T4
polynucleotide kinase and ATP for intramolecular ligation. The two amplified restricted
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fragments were combined with pCWu10, treated with KpnI and BamHI in the presence
of T4 DNA ligase.
pDagASv – The agarase gene (dagA) was amplified from Streptomyces
violaceoruber M145 gDNA using primers dagASv-F and dagASv-R. To drive expression,
the EF-Tu (ana_0022) promoter was cloned upstream of dagA using the primers promEF-tu-F and prom-EF-tu-R. To facilitate ligation, prom-EF-tu-F was designed with a KpnI
restriction site and GFP-R was designed with a BamHI restriction site. The GFP
fragment was treated with T4 polynucleotide kinase and ATP to facilitate intramolecular
ligation. The two amplified restricted fragments were combined with pCWu10 treated
with KpnI and BamHI in the presence of T4 DNA ligase.
DagA and GFP reporter plasmids – Inverse PCR was used to insert signal
peptides between the EF-tu promoter and dagA or gfp sequence, the signal peptide
fragment contained a 5’ phosphate and 3’ restriction site that was complementary to the
restriction site on the reporter gene.
pCWu2-∆tatC – 1 kb upstream and downstream the tatC (ana_0769) open
reading frame was amplified using primer pairs tatCup-F and tatCup-R and tatCdn-F and
tatCdn-R. tatCup fragment was engineered with a 5’ KpnI and 3’ HindIII restriction site,
and the tatCdn fragment was engineered with a 5’ HindIII and 3’ EcoRI restriction site to
facilitate ligation of the fragments as well as the pCWu2 vector digested with KpnI and
EcoRI in the presence of T4 DNA ligase.
ptetR- Ω -TatC – The tetR-Ω inducible promoter was amplified from the ptetR-ΩsrtA plasmid using tetR-Ω-F engineered with a KpnI restriction site and tetR-Ω-R
primers. The tatC open reading frame was amplified using primers tatC-F and tatC-R,
and the reverse primer was designed with an EcoRI restriction site. The digested tatC orf
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fragment was treated with T4 polynucleotide kinase and ATP for subsequent
intramolecular ligation. The vector pCWu9 was digested with KpnI and EcoRI and ligated
with the tetR-Ω and tatC fragments.
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Table 2-2. Plasmids used in these studies
Plasmid
pJRD215
pRMC2
pCVD047
pCWU10

Description
Actinomyces/E. coli shuttle vector, KmR, SmR
a tetracycline-inducible expression vector
Broad host range vector
Actinomyces/E.coli shuttle vector, KmR. A
derivative of pCVD, a generous gift from Dr. Golden
A derivative of pTetR-SrtA with a riboswitch element
pTetR--SrtA
incorporated upstream of the start codon ATG
pGspA
pJRD215 expressing GspA
pGspA∆cws
pJRD215 expressing GspA lacking the cell wall
sorting signal (CWS)
pFimA∆cws
pCWU10 expressing fimA under the srtC2
promoter, lacking the cell wall sorting signal (CWS)
pLepB2
pJRD215 expressing lepB2
pLepB2(S101A)
pJRD215 expressing lepB2 with the mutation
S101A
pLepB2(K169A)
pJRD215 expressing lepB2 with the mutation
K169A
pCWU2
Derivative of pHTT177, expressing GalK under the
control of the rpsJ promoter
pCWU2-∆lepB1
An allelic replacement vector of lepB1 using
pCWU2
pCWU2-∆lepB2
An allelic replacement vector of lepB2 using
pCWU2
pCafA∆cws-H6
pCWU10 expressing CafA lacking the cell wall
sorting signal (CWS) containing a 6xHis tag
pMCSG7
Expression vector for protein purification
pKO-0299
pCWU2 derived KO plasmid ∆lcpB
pKO-1578
pCWU2 derived KO plasmid ∆lcpD
rLcpA
pMCSG7 expressing LcpA(78-370)
rLcpA(R149A)
rLcpA with the mutation R149A
rLcpA(∆s-s)
rLcpA with the mutation C179A/C365A
pLcpA
pCWu10 expressing LCP from native promoter
pLcpA(R128A)
pLcpA with the mutation R128A
pLcpA(R149A)
pLcpA with the mutation R149A
pLcpA(R266A)
pLcpA with the mutation R266A
pLcpA(C365A)
pLcpA with the mutation C365A
pLcpA(C179/365A) pLcpA with the mutation C179/365A
pVKOR-2HA
pCWU10 expressing VKOR with double C-terminal
influencza hemagglutinin (HA) tag
pGspAΔcws-H6
pCWU10 expressing GspA lacking the cell
wall sorting signal (CWS) with Hisx6 tag
rGspA
pMCSG7 expressing GspA(31-286)

Reference
(82)
(90)
(87)
(80)
(50)
(50)
(80)
(80)
(80)
(80)
(80)
(79)
(80)
(80)
This study
(89)
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
(64)
(80)
This study
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pCafA

pCWu10 expressing cafA from native promoter

This study

pCafA(K111M)
pCafA(R123H)
pCafA(Y145R)
pCafA∆cws-H6

pCafA with K111M mutation
pCafA with R123H mutation
pCafA with Y145R mutation
pCWu10 expressing CafA variant lacking the cell
wall sorting signal and containing a Hisx6 tag from
CafA promoter
pCafA∆cws-H6 with CafA(R3,4A) mutation
pCafA∆cws-H6 with CafA(R11,12A) mutation
pCafA∆cws-H6 with CafA(R25,26A) mutation
pBluescript SK expressing GFP

This study
This study
This study
This study

pCafA-RR1
pCafA-RR2
pCafA-RR3
pBsk-GFP
pGFP
pDagASv
pFimASP-DagA
pFimASP-GFP
pDagASP-GFP
pCafASP-DagA
pCafASP-GFP

pTatC-KO

ptetR-Ω-tatC

pCWu10 expressing GFP from the EF-Tu promoter
pCWu10 expressing the DagA ORF from S.
violaceoruber from the EF-Tu promoter
pCWu10 expressing FimA-SP fused to DagA
without signal peptide from the EF-Tu promoter
pCWu10 expressing FimA-SP fused to GFP from
the EF-Tu promoter
pCWu10 expressing DagA-SP fused to GFP from
the EF-Tu promoter
pCWu10 expressing CafA-SP fused to DagA
without signal peptide from the EF-Tu promoter
pCWu10 expressing CafA-SP fused to GFP from
the EF-Tu promoter
pCWu2 expressing ~1.8kb fragments upstream and
downstream of TatC ORFs for allelic exchange and
counter-selection of mutants
pCWu9 expressing tatC ORFs under transcriptional
control from a tetR inducible promoter and posttranscriptional control by a theophylline responsive
riboswitch

This study
This study
This study
Addgene plasmid
#29459 (91)
This study
This study
This study
This study
This study
This study
This study

This study

This study
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Site-directed mutagenesis. For site-directed mutagenesis of LepB2, pLepB2, rLcpA,
pLcpA and pCafA∆cws-H6 mutations were incorporated into the 5’ end of synthesized
primers (Table 2-3) for inverse PCR as previously described (50). The PCR products
were purified by gel extraction and phosphorylated to facilitate circularization of the
amplicons. After transformation into E. coli, the genes were sequenced to ensure the
mutation was present and in-frame.
Generation of nonpolar, in-frame deletion mutants in A. oris. Nonpolar, in-frame
deletion mutants used in this study were generated according to a previously published
protocol (79). Briefly, 1.0 kb DNA fragments upstream and downstream of a target gene
were PCR-amplified using appropriate primers. The two fragments were treated with
restriction enzymes and linked together by a single-step ligation. Subsequently, the 2 kb
fragment was cloned into the deletion vector pCWU2 (50). The generated plasmids were
introduced into the A.oris galK strain by electroporation. Selection of corresponding inframe deletion mutants was performed using GalK as a counter-selectable marker.
Generated mutants were characterized by PCR and/or immunoblotting.
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Table 2-3. Primers used in this study
Primer

Sequence(a)

Application

1190upF

GGCGTCTAGATCCGGACAAACCGTTCCATG CCCCGA pCWU2-∆lepB2

1190upR

GGCGAAGCTTTGCGCTGCTCATAGGCCTTC TCCTG

pCWU2-∆lepB2

1190dnF

GGCGAAGCTTGACTGATCGCCCCGAAAGCG TGCTG

pCWU2-∆lepB2

1190dnR

GGCGGAATTCACCGACCTCGTCCAGGCCGC
CGACGT

pCWU2-∆lepB2

Pro-1190F

GGCGGAATTCCCCTCGGCCGAGTCATCGGCC
GCTCG

pLepB2

pro-1190R

GGCGGGTACCCTCCTGGGATCGGGGCATGGAACGG

pLepB2

com-1190F

GGCGGGTACCGTGATGAGCAGCGCACCCGACCA
GAGC

pLepB2

com-1190R

GGCGAAGCTTTCAGTGGTGGTGGTGGTGGT
GGTCCCCG GAGCCCGCCA GCCTG

pLepB2

1188upF

GGCGGAATTCACTGATCGCCCCGAAAGCGT GCTGG

pCWU2-∆lepB1

1188upR

GGCGTCTAGAACGGGGAAGTGCAGGCCGGT GTG

pCWU2-∆lepB1

1188dnF

GGCGTCTAGAGGCCCGGACACTTACGGCGG CATGG

pCWU2-∆lepB1

1188dnR

GGCGGGTACCCTAGCCCCATGACGCATCCA CCG

pCWU2-∆lepB1

1190S101A-F

GCGATGGAGAACACCCTCAACGAGGGCG

pLepB2(S101A)

1190S101A-R

CCCCGAGATGGTGAAGCTGCTCTGGATG

pLepB2(S101A)

1190K169A-F

GCGCGGGTCATCGGAATGCCCGGTGACCACG

pLepB2(K169A)

1190K169A-R

GATGAGGTGGTGACCGGCGTTCTGGGG

pLepB2(K169A)

pCVD047noAmp-F

GGCGGAGTCATGATTTAGAAAAATAAACAAATAGGG
G

pCVD047ΔAmp

pCVD047noAmp-R

GGCGAAGCTTCTGTCAGACCAAGTTACTCATATATA

pCVD047ΔAmp

215KanMCS-F

GGCGGAGCTCTCAGAAGAACTCGTCAAGAA GGCGA

pCWU10

215KanMCS-R

GGCGAAGCTTATCG ATGATAAGCTGTCAA

pCWU10

GspA∆cws-His6R

GGCGGAATTCTCAGTGGTGGTGGTGGTGGTGGGGC
TTGCCGGAGGTGGAGGCCGCC

pGspA∆cwss

prFimB-BamHI-F

AAAAAGGATCCGACGTCACCGGTGTCATCACCCTCC

pFimA∆cwss

prFimB-R

GGGACCGCCTTCTCTTAGGCGTCG

pFimA∆cwss

FimA-F

GTGACGCCGTCGGACAAGACGGAG

pFimA∆cwss
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FimA∆cws-His6EcoRI-R

AAAAAGAATTCTCAGTGGTGGTGGTGGTGGTGAAC
CGA CTG CTT GGT GTT CTC AAC GG

pFimA∆cwss

RT-16s-R

GGTGTTGCCGACTTTCATG

RT- PCR (16s rRNA)

RT-16s-F

GTCGCTAGTAATCGCAGATCAG

RT- PCR (16s rRNA)

RT-1291F

GACGGCACCTACAAGATCAC

RT-PCR (gspA)

RT-1291R

AGGAGTCGGTCTTGCTGA

RT-PCR (gspA)

P1

CCTCCAGGTCC CGATCACAC

RT and qRT-PCR

P2

GCCTGCGGGGTTGGATAGAGG

RT and qRT-PCR

P3

CCCGGCCGGTCAGCCTCCGAGGTCG

RT and qRT-PCR

P4

GCTGGACCAGTGGGAGTATGGCCAC

RT and qRT-PCR

P5

GTGTGATCGCGGACCTGGAGG

RT- PCR

P6

GGCCATACTCCCACTGGTCCAG

RT- PCR

D0299up-F

GGCGGGTACCGTGACGAGCAGCGCCGCTGCGCT

∆lcpB

GGCGTCTAGAGCGAGGTCGTGTCGGCCCCTGACGA
G
GGCGTCTAGAGTCACGCTCGACGCCGACGCGGACA
C

∆lcpB

D0299dn-R

GGCGGAATTCAGCTCCTCAACCGCCTCGGGCAC

∆lcpB

D1578up-F

GGCGGGTACCTCTCCTACGTCCTGGAGAAGACGA

∆lcpD

D1578up-R

GGCGTCTAGAGCGATCATAGGGAACGAGACTGCTA

∆lcpD

D1578dn-F

GGCGTCTAGAGGCCAACATCGGCGAGACGGTACTG

∆lcpD

D1578dn-R

GGCGGAATTCGCGCAGATGTTGCGCACCCTCACGT

∆lcpD

rLcpA-F

TACTTCCAATCCAATGCAGCTCATCGCCCTGCACGC
G

rLcpA

rLcpA-R

TTATCCACTTCCAATGTTACTAGGCGCCCGCTGGCC

rLcpA

LcpA-F

GGATCCTCGCCTCCTTCCAGTCTGACTGG

pLcpA

LcpA-R

GAATTCCCTCGGGGTCTCTCCGGCGAGTG

pLcpA

LcpA(R128A)-F

GCCGCCGATGTCATCGCCCTGGTACGC

SDMb LcpA

LcpA(R128A)-R

GGAACCCTCCACCTCCTGAGTG

SDM LcpA

LcpA(R149A)-F

GCGGACCTGACCATCAACAGCAAGG

SDM LcpA

LcpA(R149A)-R

GGGCAGGTTGATGATGGTGACTC

SDM LcpA

LcpA(R266A)-F

GCCAGCCAGTCCACGGCCACCGTG

SDM LcpA

LcpA(R266A)-R

GCGTTGGGCGCCATCGGCC

SDM LcpA

LcpA(C179A)-F

GCCACCGGGCTCGGAATCCCCAC

SDM LcpA

D0299up-R
D0299dn-F

∆lcpB
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LcpA(C179A)-R

CAGGGCGTTGACCGTGTTCTGAGG

SDM LcpA

LcpA(C365A)-F

CGCACGGCCAGCGGGCGCCTAG

SDM LcpA

LcpA(C365A)-R

GTTTTGGGACTGTACCCATAGCGGGC

SDM LcpA

RT-lcpA-F

CGGCAGATGGGTGACCATGAGC

RT-PCRc

RT-lcpA-R

CAGTGCGGCCAGGTCGCTGAG

RT-PCR

L/CafA(K111M)

TACTTCCAATCCAATGCATCCCTCGCCTTCAAGATCG
CCG
TTATCCACTTCCAATGTTACTTGCCGGAGGTGGAGG
CCGC
ATCGCCGGAGATCCGTGAGGG

R/CafA(K111M)

ATGTGGCGAACCAGTCGATGCACC

SDM CafA

L/CafA(R123H)

CACATTGGATAGGGTGCATCGACTGG

SDM CafA

R/CafA(R123H)

CACACCACTGCCGTGGGAAAGAATGAG

SDM CafA

L/CafA(Y145R)

GTATCCGACACTCAGGCCCCGG

SDM CafA

R/CafA(Y145R)

CGTCCGGGTAACTGGAGGGGAGACG

CafA-pro-F

GGATCCCAAGAAGCGCGTCGTAGATCTCCCAG

SDM CafA
pCafA, pCafA∆cws-H6

CafA∆cws-H6-R

pCafA∆cws-H6

CafA-RR1-F

GGTACCTCAGTGGTGGTGGTGGTGGTGCACCGCCG
ACTTGCGGTTG
GCCGCATTCTTTGTCCGCTCACACCGGCGG

CafA-RR1-R

AAGCATGAAGCGCTACCTCAGTTTTAGGGTC

pCafA-RR1

CafA-RR2-F

GCGGCGGAACTGACGTCATCACGTCAACCCTCA

pCafA-RR2

CafA-RR2-R

GTGTGAGCGGACAAAGAATCGGCGAA

pCafA-RR2

CafA-RR3-F

GCTGCGAGACTGAGGAGCGGCGCCGCCATCTCG

pCafA-RR3

CafA-RR3-R

AGACTGGCGTGAGGGTTGACGTGATGACGTC

pCafA-RR3

PromEF-Tu-F

GGTACCCTGCCTCCGGGGTCCGCACC

PromEF-Tu-R

TGGTGTCCTCCTGGGACTCGGGTAG

DagASv-F

GTGGTCAACCGACGTGATCTCATCAAG

GFP and DagA
reporters
GFP and DagA
reporters
pDagASv

DagASv-R

GGATCCCTACACGGCCTGATACGTCCTGAC

GFP-F

ATGTCTAAAGGTGAAGAACTGTTCACCG

GFP-R

GGATCCCTATTTGTAGAGCTCATCCATGCCGTG

DagASP-R

GAGGTCTGCGGCATGAGCGGC

FimASP-F

ATGAAGCACAACGCCAGCACGCTG

rGspA-F
rGspA-R

rGspA
rGspA
SDM CafA

pCafA-RR1

pDagASv and
derivatives
pGFP, pDagASPGFP, pFimASP-GFP,
pCafASP-GFP
pGFP, pDagASPGFP, pFimASP-GFP,
pCafASP-GFP
pDagASP-GFP
pFimASP-GFP,
pFimASP-DagA
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FimASP-R

CGTTTCCGTGGCCACGGCC

CafASP-R

GGCCTCAGCCGGGGGAGCCG

TatC-up-F
TatC-up-R

GGTACCCTGGCCTGCTTGACGGCCTTAAGCAG
AAGCTTCTTCACCCCGTCCCTGCCTGACTTG

pFimASP-GFP,
pFimASP-DagA
pCafASP-GFP,
pCafASP-DagA
pTatAC-KO
pTatAC-KO

TatC-dn-F

AAGCTTGATGGTTCTCCCCAAGGCGGACGG

pTatAC-KO

TatC-dn-R

GAATTCGACTACACTTTGCCCGCGCTGCAC

pTatAC-KO

tetR-Ω-F

GGTACCTTAAGACCCACTTTCACATTTAAGTTG

pTetR-Ω-tatC

tetR-Ω-R

CTTGTTGCCTCCTTAGCAGGGTG

ptetR-Ω-tatC

TatC-F

GTGAACCTCTTTAAGCCGTCGCAC

pTetR-Ω-tatC

TatC-R

GAATTCCTACTCGGCCAGGGCGGCCTCGAG

pTetR-Ω-tatC

RT-cafA-F

GCGCGGTAAGACCGCCTCAG

cafA, qRT-PCR

RT-cafA-R

CGGCCGACTTGGGAGACGATG

cafA, qRT-PCR

RT-16s-F

GTCGCTAGTAATCGCAGATCAG

16S rRNA, qRT-PCR

RT-16s-R

GGTGTTGCCGACTTTCATG

16S rRNA qRT-PCR

a

Engineered restriction sites are underlined

b

SDM – primers used for site directed mutagenesis by inverse PCR

c

RT-PCR – reverse transcription PCR
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Cell growth assays. A. oris growth was assessed by a plate assay and optical density
(OD600) according to a previous protocol (50). For the plate assay, overnight cultures of
various strains were harvested and normalized to the same OD600 in HIB. Equivalent cell
suspensions were subjected to 10-fold serial dilution and spotted on HIA plates
supplemented with or without 100 ng mL-1 AHT and 2 mM theophylline. Cell growth at
37oC was recorded after 3 days. For growth in liquid broth, strains were sub-cultured to
OD600 of ~ 0.02. Cell growth was monitored by OD600 over 19 h. The OD values were
presented as an average of three independent experiments performed in duplicate.
Reverse transcriptase and quantitative real-time polymerase chain reactions.
Overnight cultures were used to inoculate fresh cultures of various A. oris strains, which
were grown until OD600 ~ 0.25. Cells were harvested by centrifugation, and cell pellets
were suspended in Trizol (Ambion) and lysed by mechanical disruption using 0.1 mm
silica spheres (MP Bio). Total RNA was extracted using a Direct-zol RNA MiniPrep kit
(Zymo Research). Complementary DNA (cDNA) was synthesized using SuperScript III
reverse transcriptase (Invitrogen). For quantitative real-time PCR, cDNA was mixed with
iTAQ SYBR green supermix (Bio-Rad), along with appropriate primer sets (Table 2-3).
Threshold concentration (Ct) values were determined and the relative expression level
was calculated using the 2-∆∆Ct method (92) with the 16s rRNA gene serving as an
internal control. The data were obtained from three independent experiments performed
in triplicate.
Cell fractionation and immunoblotting. Overnight cultures of A. oris strains were
diluted 40-fold in HIB and grown at 37°C until OD600 ~ 0.4 - 0.5. Normalized aliquots
were subject to cell fractionation as described previously (93). Protein samples obtained
from supernatant (S), cell wall (W), membrane (M) and cytoplasm (C) fractions were
analyzed by 15% or 3-20% polyacrylamide gels, separated by SDS-PAGE, and
immunoblotted with specific antibodies (1:1,333 dilution for -GspA; 1:10,000 for 39

FimP; 1:8,000 for -FimA and 1: 4,000 for -MdbA; 1:10,000 dilution for -GspA;
1:1,000, affinity purified -LcpA; and 1:8,000, -SrtA; 1:8,000 for -CafA). The proteins
were detected by chemiluminescence.
LcpA signal from four independent blots was normalized against a Coomassie
R250 stained loading control band from the same blot and quantified using ImageJ,
https://imagej.nih.gov/. The obtained intensity values were normalized to those of the
wild-type strain, which were set to 1. The results were presented as average of four
independent experiments.

Protein purification and analysis. Recombinant plasmids pGspAΔcwss and pFimAΔcwss
generated above were introduced to A. oris strains containing combinations of the signal
peptidases lepB1 and lepB2 by electroporation. Each strain was inoculated into 200 mL
HIB supplemented with 50 g mL-1 kan and grown overnight. The cell-free cultures were
obtained by centrifugation and filtration using 0.45 µm-pore size filters. 2 ml of nickel
resin, washed twice with EQ buffer (150 mM NaCl, 50 mM Tris.HCl, pH 7.5) were added
to the supernatants and gently agitated at 4°C overnight. The suspensions were
decanted onto a protein purification column, which was then washed with 20 ml EQ
buffer. Bound proteins were eluted in 3-ml fractions with 1 M imidazole. The eluted
proteins were desalted using a desalting column (BioRad), and concentrated using an
Amicon Ultra 0.5 mL centrifugal unit (Millipore) with 10K (GspA) or 30K (FimA) cutoff.
GspALMM was purified as above for pGspA∆cwss from the ∆lcpA background.
rLcpA and alanine substitution mutants – generated as described above, were
introduced into E. coli SHuffle for protein purification. The strains were inoculated into
500 mL of LB supplemented with 100 Amp µg mL-1 and grown to OD600 = 0.8 at 30°C.
Protein expression was induced using 0.1 mM IPTG and the culture was transferred to
16°C overnight. Cells were pelleted by centrifugation and washed by suspension in EQ
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buffer (150 mM NaCl, 50 mM Tris HCl, ph 7.4). Cells were treated with 1X protease
inhibitor cocktail (GenDEPOT). The treated cells were chilled and then lysed with a
French press. Lysates were centrifuged to remove cell debris and nucleic acids. The
remaining soluble fraction was decanted onto an equilibrated NiNTA column (Qiagen).
The bound proteins were washed with up to 100 mM imidazole to remove nonspecific
proteins, and eluted with 500 mM imidazole in wash buffer (1X EQ and 10% glycerol).
Imidazole was removed from the eluates with a desalting column (Bio-Rad) exchanged
with wash buffer.

Purified proteins were analyzed by SDS-PAGE and visualized with Coomassie
Blue and Periodic acid-Schiff staining as previously described (50).

For Edman sequencing, the proteins were transferred to a PVDF membrane. The
membrane was rinsed with ultrapure water and stained with 0.02% Coomassie Brilliant
blue for 30 seconds followed by de-staining in 40% methanol, 5% acetic acid solution for
1 minute and rinsed with ultrapure water 3 times. The membrane was completely airdried, and protein bands were excised for Edman sequencing at the TUCF core facility
(Tufts University).

CafA was purified from the supernatant of A. oris cells transformed with the
pCafA∆CWS-H6 plasmid. One liter of cells was grown to OD = 0.8, and then the cells were
centrifuged twice to collect the cell-free supernatant. To remove remaining cells, the
supernatant was filtered through a vacuum filtration device (Olympus) with a 0.45 µM
pore. The supernatant was then treated with 1X protease inhibitor cocktail (GenDepotXpert) and decanted onto a CapturemTM His-Tagged Purification Large Volume unit
twice. The column was washed twice with EQ buffer, and the proteins were eluted with
30 mL of 0.5 M imidazole in EQ buffer. The eluate was desalted using a size exclusion
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column (Bio-Rad) exchanged with EQ buffer, and concentrated using a 15 mL
centrifugation filter with a 50K cutoff according to manufacturer instructions (Millipore).

Coaggregation and biofilm assays. Coaggregation between A. oris and Streptococcus
oralis was assayed according to a previously published protocol (93). Briefly, stationary
cultures of A. oris and S. oralis were collected by centrifugation, washed, and suspended
in coaggregation buffer (93). To quantify coaggregation, optical density (OD600) of
individual A. oris and S. oralis cell suspensions in coaggregation buffer was measured.
Equal cell volumes (0.5 ml) were mixed and allowed to form aggregates. The resulting
aggregates were photographed by an Alpha-Imager or removed by centrifugation at 100
x g, and OD600 of the remaining supernatants were recorded. Relative coaggregation
was determined as previously described (94).
A. oris biofilms were cultivated in vitro as reported before (79). Briefly, cells were
inoculated in HIB supplemented with 1% sucrose in a 24-well polystyrene plate and
incubated at 37°C with 5% CO2 for 48 h. After incubation, the media was removed, and
each well was gently washed with PBS three times and dried over night at room
temperature. Biofilms were stained with 1% crystal violet and washed with water to
remove the unbound dye. To quantify biofilm production, the biofilms were destained
with 95% ethanol and the released dye was quantified by measuring absorbance at 580
nm using a Tecan Infinite M1000 microplate reader. The assays were performed three
times in triplicate.

Whole-cell ELISA. Surface expression of A. oris tip proteins was quantified by wholecell ELISA as previously described with some modifications (95,96). Briefly, mid-log
phase cells of A. oris MG1 and its isogenic mutant strains were harvested by
centrifugation and washed twice with phosphate-buffered saline (PBS). The cells were
suspended in carbonate-bicarbonate buffer (15 mM sodium carbonate, 35 mM sodium
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bicarbonate, pH 9.6) and normalized to an OD600 of 1.0. 100-L aliquots of cell
suspensions were dispensed into 96-well high-binding ELISA plates (Corning Costar
EIA/RIA plate) to allow cell binding to wells at 4°C overnight. Unbound cells were
removed by washing with PBS containing 0.05% Tween 20 (PBST). Adhered cells were
blocked with 2% bovine serum albumin (BSA) in PBST prior to incubating with specific
antibodies against CafA and FimB (1:10,000) for 2 h at 25oC, followed by washing with
PBST, and staining with anti-rabbit IgG HRP-linked antibodies (Cell Signaling; 1:20,000)
for 1 h at 25oC. Washed cells were treated with 100 L of the chromogenic 3,3′,5,5′Tetramethylbenzidine (TMB) substrate (Affymtrix eBioscience) prior to absorbance
measurement at 450 nm using a Tecan M1000 plate reader. The absorbance for MG1,
∆lepB1, and ∆lepB2 strains as compared with the ∆cafA and ∆fimB mutants used as
background was determined from at least two independent experiments performed in
triplicate.

Immunogold-labeling and electron microscopy. Pili were visualized by electron
microscopy (EM) as previously described (62). Briefly, A. oris cells grown in HIB were
pelleted, washed once, and suspended in 0.1 M NaCl. For negative staining, a drop of
bacterial suspension was placed onto carbon-coated nickel grids and stained with 1%
uranyl acetate before viewing with a JEM1400 electron microscope. For immunogold
electron microscopy (IEM), after immobilizing cells on the nickel grids, samples were
stained with specific antibodies (-FimP, 1:100 dilution; -FimA, 1:100 dilution) followed
by incubation with 12-nm gold-goat anti-rabbit IgG (Jackson ImmunoResearch). Finally,
the samples were washed five times with water before staining with 1% uranyl acetate.
Pyrophosphatase assay. This assay uses a 24-hour endpoint reaction of rLcpA and its
derivatives combined with farnesyl pyrophosphate (FPP) to detect the amount of
phosphate released. LcpA concentration for all assays was 3 µM, and FPP substrate
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was titrated as indicated. The reactions were buffered in 20 mM Tris-HCl (pH 8.0), and
incubated for 24 hours at 30°C (97). Controls for LcpA only and FPP only were included
for each reaction to determine any nonspecific signal. To detect release of inorganic
phosphate a Phosphate Fluorometric Assay Kit (MAK031, Sigma) was used according to
manufacturer instructions. The presence of inorganic phosphate leads to the conversion
of sucrose to glucose-1-phosphate via an enzymatic reaction. The gluose-1phophosphate is then oxidized and reacts with a probe, which results in the release of a
fluorescent signal proportional to the amount of phosphate in the sample. The phosphate
detection master mix was added to either a phosphate standard or the endpoint samples
in a black 96-well plate and then incubated in the dark for 1 h. The fluorescence from
each sample was measured by a Tecan microplate reader at λex = 535/λem = 587 nm.
Results from the phosphate standards were used to generate a standard curve and
included for each biological replicate. Each run also included a zero standard, which did
not include any phosphate and this was used to determine background fluorescence to
be subtracted from all readings. Linear regression analysis of the standard curve was
used to determine the concentration of phosphate in the test samples. Non-linear
regression and statistical analyses were performed in Prism GraphPad (version 5.04).
Phosphotransferase assay and 2D protein electrophoresis. 12 µM GspALMM was
incubated with 4 µM of LcpA (WT or R149A) and 50 µM of FPP in 20 mM Tris-HCl (pH
8.0) for 72 h at 30°C. After incubation, the protein samples were treated with hydrofluoric
acid (HF) following published protocols (48,98-100) or mock-treated with H2O. Briefly,
protein samples were treated with 46% HF at 4°C for 18 h. After acid removal by
vacuum evaporation, the protein samples were washed with 500 µL of deionized water
followed by vacuum evaporation.
To resolve GspA modified by a phosphate group, samples were solubilized for 30
mins at 25°C in rehydration buffer (Bio-Rad). To resolve GspALMM species by isoelectric
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point, we used an 11 cm IPG strip with a narrow linear range (pH 3 – 6) (Bio-Rad). The
sample was added during the rehydration step and overlaid with mineral oil. The IPG
strips were rehydrated actively (50 V) with the sample for 12 hours, then the voltage was
increased rapidly to a max of 8,000 V for the isoelectric focusing step with a Protean IEF
system (Bio-Rad). After IEF, the IPG strips were placed onto a 4 – 20% Criterion™
TGX™ IPG+1 gel (Bio-Rad) in overlay agarose (0.5% agarose in 1X Tris/Glycine/SDS
(TGS) buffer and 0.003% bpb) alongside a precision plus protein™ dual color standard
(Bio-Rad). After the overlay agarose was set, 1X TGS buffer was added and the
samples were run at 200 V for 57 min. The proteins were then transferred to a PVDF
membrane for subsequent immunoblotting as above with an α-GspA antibody.
HGF-1 bacterial adherence assay. Human gingival fibroblast (HGF-1) cells (ATCC®
CRL-2014™) were grown in DMEM with 10% fetal bovine serum (FBS) and
penicillin/streptomycin (Thermofisher Scientific) (DMEM +/+) at 37°C in 5% CO2 until
100% confluency. For the adherence assay 6-well plates were seeded at a density of 6.0
x 104 cells/well, and allowed to reattach in DMEM +/+ for 48 hours at 37°C in 5% CO2
(101). Bacterial cells were grown to midlog phase from overnight cultures, washed in
Dulbecco’s phosphate buffered saline (DPBS), and then normalized to 1 x 108 cells. The
washed cells were diluted 1:100 in DMEM with 10% fetal bovine serum (FBS) without
antibiotics (DMEM+/-) and plated for the colony forming unit (cfu) input count. Each strain
was plated in triplicate for each experiment. Meanwhile, the HGF-1 cells were treated
with 2U neuraminidase/sialidase (Clostridium perfringens; Sigma) and 1X protease
inhibitor cocktail (GenScript) for 2 hours at 37°C in 5% CO2 in DMEM without FBS or
antibiotics (DMEM-/-). After washing sialidase from HGF-1 cells in DMEM+/-, 200 µL of 1
x 106 A. oris cells were added for a final multiplicity of infection (MOI) of 200 bacterial
cells/HGF-1 cell. The plates were centrifuged at 200 x g for 5 min and then incubated 2
hours at 37°C in 5% CO2. HGF-1 cells were lysed with cold water and vigorous pipetting.
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Bacterial cells were enumerated by plating for cfu/mL on HIA in duplicates per well.
Adherence assay were all performed in technical triplicates with duplicate enumeration,
and each assay was replicated three times independently.
Genomic DNA sequencing. Genomic DNA (gDNA) sequencing steps were performed
at CARMiG by An Dinh. First, gDNA was isolated from 1 mL of cells from overnight
cultures of A. oris MG1, N11A16, N32A8, and N11A12 according to the DNeasy Blood &
Tissue Purification Kit (Qiagen) instructions for Gram-positive bacteria. To determine the
concentration and quality of the prepared gDNA Qubit dsDNA High Sensitivity kit and gel
electrophoresis were used. Samples were diluted to 0.2 ng/µL. A gDNA library was
prepared using Nextera XT Library Prep kit (Illumina) according to manufacturer
instructions. Libraries were assessed for yield (Qubit), and average insert size using
Agilent D5000 High Sensitivity ScreenTape on Agilent 4200 TapeStation. Normalized
sample libraries were pooled to achieve 80-fold genome coverage depth, and then
denatured and diluted to 12 pM with a 1% PhiX spike-in control. Sequencing was
performed on an Illumina MiSeq platform with MiSeq V2 reagent kit. Paired-end reads
with onboard Illumina base-calling and adapted-trimming to yield *.fastq files. CLC
Genomics workbench was utilized to filter, trim, and de novo assemble the reads. The
data was analyzed using the comparative analysis platform EDGAR.
Agarase clearance assay. To determine whether signal peptides were sufficient to
export proteins via the Tat pathway, we utilized a modified version of the agarase assay
originally developed for testing heterologous signal peptide fusions from Streptomyces
coelicolor in Streptomyces lividans (102,103). A. oris cells expressing native DagA,
DagA signal peptide fusions, or an empty vector control were grown to mid logarithmic
phase in HIB with kanamycin, and then concentrated to OD600 of 2.0. Three microliters of
concentrated cells were spotted onto HIA and grown for 48 hours at 37°C with 5% CO 2.
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Lugol solution (Sigma) was added to the plates for 1 h, then decanted to image the zone
of clearance.
Fluorescence intensity measurements. Fluorescence intensity of was measured from
the supernatant of bacterial cells grown in HIB or from cells washed and suspended in
PBS. A blank measurement was made for HIB or PBS alone, depending on the sample.
Additionally, a gain reference was made using 40 µg/mL purified GFP in either HIB or
PBS. The mean of technical triplicates was measured and averaged. Overall
percentages of fluorescent signal in the media compared to the whole cell were
calculated from three independent experiments. The time-course fluorescence was only
taken from the media fraction and assessed every hour for 8 h with a final reading at 18
h.
Fluorescence microscopy. 10-well multi-test slides (MP Biomedicals) were prepared
by adding 2 μL of 1.5% agarose in 1X PBS. Bacterial samples grown to mid-log phase
were centrifuged, washed with 1X PBS, pipetted onto an individual agarose pads, and a
cover slip was placed over the slide to secure the samples. Images were obtained on an
Olympus IX81-ZDC inverted microscope using Slidebook imaging software. Fluorescent
images were taken at 0.5 sec exposure with 255 gain and exported as TIFF files.
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CHAPTER III
A Type I Signal Peptidase is Required for Pilus Assembly
in the Gram-positive, Biofilm-forming Bacterium
Actinomyces oris
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The results and figures in this chapter are from work published in 2016: Siegel SD, Wu
C, Ton-That H “A type I signal peptidase is required for pilus assembly in the Grampositive biofilm-forming bacterium Actinomyces oris.” J Bact. 198(15):2064-73. doi:
10.1128/JB.00353-16. I am the first author of this publication and was responsible for
preparing the original manuscript and conducting the experiments described in this
paper. I have permission to reproduce any and all of this manuscript, in print or
electronically, for the purpose of my thesis in accordance with the American Society for
Microbiology (publisher of Journal of Bacteriology) “Journals Statements of Authors’
Rights.” http://journals.asm.org/site/misc/ASM_Author_Statement.xhtml.

Introduction
The role of the housekeeping sortase in Gram-positive bacterial pathogenesis has been
demonstrated in a diverse abundance of species. For example, in S. aureus deletion of
housekeeping sortase results in attenuation of pathogenicity in several different models
of infection (104). This is due to the reduction of anchored virulence factors on the cell
surface, such as protein A, the paradigm sortase substrate. Similar virulence-associated
phenotypes have also been implicated in other Gram-positive bacteria including Listeria
monocytogenes, Streptococcus pneumoniae, and Bacillus anthracis (105-107).
In an effort to identify how deletion of the A. oris housekeeping sortase affects
biofilm formation it was discovered that it is essential for cell viability, a feature unique to
this species (50). While the sortase cannot be deleted or catalytically inactivated, it was
possible to delete all predicted LPXTG containing proteins (25). This led to the
hypothesis that a toxic protein may accumulate at the membrane in the absence of
housekeeping sortase. Using a transposon screen for suppressors of ∆srtA lethality, 13
suppressor mutants were identified, and two were characterized further. The two
proteins, which were characterized after the transposon screen, were LCP (LytR-CpsA49

Psr) and AcaC (Actinomyces cell wall associated protein C). These genes are clustered
in the genome and both had multiple transposon hits. AcaC (now GspA) was
glycosylated in an LCP-dependent manner and required SrtA for anchoring. A model
was proposed that accumulation of glycosylated GspA in the membrane in the absence
of sortase leads to membrane glycol-stress and eventual cell death (50).
Additional mutations that could suppress ∆srtA lethality were identified from the
original transposon mutagenesis screen. We hypothesized that glycosylation or
anchoring pathway of GspA was central to the essentiality of srtA. Thus, all of the
mutations were specifically associated with one of the two pathways. One such mutation
was found to disrupt the open reading frame of ana_1190, annotated as a putative type I
signal peptidase (SPase) and renamed lepB2 (50).
Secreted proteins encode a signal peptide at the N-terminus. After secretion, the
non-lipoprotein signal peptides are cleaved by a bacterial type I SPase. This constitutes
the terminal step of the secretion pathway. Type I SPases are endopeptidases that
utilize a serine-lysine catalytic dyad. SPases recognize an AxA motif that is a broadly
conserved cleavage sequence among Gram-negative and Gram-positive bacteria (53).
Gram-negative bacteria generally encode only a single essential type I SPase, however,
Gram-positive bacteria often encode several SPases, some of which cleave only specific
substrates (60,108,109).
In this work, we investigated the role of LepB2 in the GspA glycosylation and
anchoring pathway and determined that it is dispensable for GspA signal peptide
cleavage. Rather, it modulated the glycosylation of GspA, and may have specifically
impacted a yet unknown glycosylation enzyme. We further showed that LepB2 does
cleave the signal peptide of pilin proteins and that signal peptide cleavage is required for
pilus polymerization. Improper cleavage of the signal peptide impacted bacterial
physiology.
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Results
The type I signal peptidase LepB2 is a genetic suppressor of srtA essentiality –
We have previously reported that A. oris srtA is an essential gene and identified the
Tn5::lepB2 mutation as one of the genetic suppressors of srtA essentiality (50). lepB2 is
genetically linked to trmD and rimM, which encode a tRNA (guanine(37)-N(1))methyltransferase and a 16S rRNA processing protein, respectively (Fig. 3-1A).
According to the BioCyc databases, http://biocyc.org/, the three genes are predicted to
be expressed as one transcription unit in Actinomyces naeslundii Howell 279 (110).
Farther upstream of lepB2 is another signal peptidase-encoding gene annotated as
lepB1 (Fig. 3-1A). To exclude the possibility that the Tn5::lepB2 has a polar effect on
adjacent genes, we created in-frame, nonpolar deletion mutations by allelic exchange
(79) including the lepB2/srtA double deletion mutation (lepB2/srtA). At first, we
generated a lepB2 mutation which enabled further deletion of srtA from the bacterial
chromosome without ectopic expression of SrtA. Of note, we were unable to delete srtA
from a lepB1 mutant strain. The lepB2/srtA strain and respective single mutations
were assessed for their ability to grow in laboratory conditions using both plate and liquid
broth assays (50). In the plate assay, normalized cell cultures were spotted in serial
dilution on HIA plates and grown at 37oC. Compared to the conditional srtA deletion
mutant, which failed to grow in the absence of two inducers anhydrous tetracycline
(AHT) and theophylline (50), the lepB2/srtA mutant did not display any visible defects
when grown in any conditions (Fig. 3-1B). Growth of gspA, lepB2, lepB1 and
lepB1/lepB2 mutants was comparable to that of the parental strain MG1 (Fig. 3-1B).
Nonetheless, when grown in liquid broth, the ∆lepB2 and lepB1/lepB2 mutants
displayed a slight growth defect as compared to the MG1 and lepB1 strains (Fig. 3-1C).
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Figure 3-1: Signal peptidase LepB2 is a genetic suppressor of SrtA essentiality.
(A) Shown is a graphic representation of the lepB2 gene locus from A. oris MG1. This
locus encodes a ribonuclease H (rnhB), SPase I (lepB1), a ribosomal protein L19 (rplS),
SPase I (lepB2), a tRNA (guanine-N1)-methyltransferases (trmD), and a 16S rRNA
processing protein (rimM). (B) Growth of wild-type MG1, conditional srtA mutant, and
non-polar deletion mutant strains on solid media in the presence or absence of inducers
anhydrotetracycline (AHT) and theophylline. (C) Growth of A. oris MG1, ΔlepB1, ΔlepB2
and ΔlepB1/ΔlepB2 was determined in liquid media. The optical density (OD600) values
were presented as an average of three independent experiments done in duplicate.
Symbols * indicate the p values less than 0.05 that were determined using the paired,
two tailed t-test with Prism GraphPad.
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We next examined if lepB1 and lepB2 are part of a transcriptional unit using
reverse transcription polymerase chain reaction (RT-PCR) as previously described
(111). Total RNA isolated from MG1 was used in reverse transcription reactions to
produce cDNA. As shown in Fig. 3-2A and 3-2B, RT-PCR detected the presence of
lepB1 or lepB2 transcripts using probes specific for lepB1 (P1 and P2 primers) or lepB2
(P3 and P4), respectively. Neither transcript was observed in the absence of reverse
transcriptase (RT), indicative of no gDNA contamination. No transcripts were detected
using probes specific for the region encompassing lepB1 and lepB2 (P5 and P6),
whereas the same probes enabled amplification of this region from gDNA (Fig. 3-2B, g
lanes). To ascertain whether deletion of lepB2 does not affect lepB1 expression, we
examined expression levels of both genes using quantitative real-time PCR (qRT-PCR).
Compared to the wild-type strain, relative expression of lepB1 or lepB2 was not altered
when lepB2 or lepB1 was deleted, respectively (Fig. 3-2C) suggesting that lepB1 and
lepB2 are independently expressed. Altogether, the results in Figures 1 and 2 confirmed
that LepB2 is a genetic suppressor of srtA deficiency and suggest that LepB2 is required
for processing of substrates that are involved in the SrtA-mediated glycosylation
pathway.
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Figure 3-2: lepB1 and lepB2 are independently expressed. (A) Specific primers (P)
were designed to detect lepB1, lepB2 and a region encompassing both. Brackets and
numbers specify the primer position and sizes of amplicons. (B) Using specific primers in
(A), reverse transcription PCR (RT-PCR) was employed to determine if lepB1 and lepB2
are independently expressed. Plus and minus signs indicate RT-PCR reactions were
performed in the presence and absence of reverse transcriptase (RT). PCR reactions
with genomic DNA (g) were used as control. (C) Quantitative real-time PCR (qRT-PCR)
was employed to determine the expression levels of lepB1 and lepB2 relative to the
parental strain MG1, using the 2-ΔΔCt method, where 16s rRNA serves as the internal
control. The data were presented averages of three independent experiments performed
in triplicate; error bars represent standard deviation (SD).
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Involvement of SPases LepB1 and LepB2 in GspA glycosylation – We previously
showed that glycosylated GspA is a substrate of SrtA since depletion of srtA leads to the
membrane accumulation of glycosylated GspA causing lethal phenotypes (50).
Subsequent Tn5 mutagenesis identified viable mutants that lack both srtA and gspA or
srtA and lepB2 (50). In this work, we have confirmed that LepB2 is a genetic suppressor
of srtA essentiality by generating a nonpolar deletion mutant devoid of srtA and lepB2
(Fig. 3-1). Therefore, we hypothesized that LepB2 works on the same GspA
glycosylation pathway by processing GspA before it is glycosylated and then anchored
to the cell wall by sortase SrtA. To examine this possibility, we first examined the status
of GspA glycosylation in the absence of SPases by analyzing GspA proteins isolated
from the culture medium (S), cell wall (W), membrane (M), and cytoplasmic (C) fractions
of wild-type and SPase mutant strains. Protein samples were immunoblotted with
antibodies against GspA and MdbA, a membrane-bound protein as a control (62). In the
wild-type MG1 strain, glycosylated GspA polymers (GspAP) were detected as smeared
bands in the cell wall fraction, and no GspA signal was observed in the gspA mutant
(Fig. 3-3A, first 8 lanes), as previously reported (50). While the lepB1, lepB2, and
lepB1lepB2 mutants did not exhibit significant defects in GspA glycosylation, the
lepB2srtA double mutant failed to produce wild-type levels of GspA polymers.
Instead, the accumulation of three low molecular weight (LMW) species was detected in
the cell wall fraction, in addition to a 50-kDa species observed in the culture medium and
membrane fractions (Fig. 3-3A, lanes lepB2srtA). To determine whether the observed
defects might be due to low expression levels of gspA, we quantitated gene expression
by qRT-PCR. Overall, no significant reduction in gene expression levels was observed in
the mutant strain when compared with the wild-type strain (Fig. 3-3B).
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Figure 3-3: Involvement of SPases in sortase-associated GspA glycosylation. (A)
Cells were grown to mid-log phase and normalized by optical density. Culture
supernatant (S), cell wall (W), membrane (M), and cytoplasmic (C) fractions were
separated by SDS-PAGE and immunoblotted with antibodies against GspA (α-GspA)
and membrane protein MdbA (α-MdbA), which served as loading and fractionation
controls. Brackets designate glycosylated, high molecular weight (HMW) species of
GspA polymers (GspAP). (B) The relative expression level of gspA in indicated strains
was determined by qRT-PCR as described in Fig. 2. Error bars are the SD from two
independent experiments performed in triplicate.
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Altogether, the results suggest that either LepB1 or LepB2 is sufficient for cleavage of
the cell wall-anchored glycoprotein GspA and that LepB2 may process factors involving
GspA glycosylation.
Specificity of A. oris SPases for processing of LPXTG-containing proteins – GspA
is one of 18 cell wall-anchored proteins with a CWSS and a putative signal peptide. A
typical signal peptide is comprised of a net positive charged region (n-region), followed
by a hydrophobic region (h-region) and a cleavage region (c-region) (53) (Fig. 3-4A).
The c-region harbors a typical cleavage site, i.e. an AXA motif, which is recognized and
cleaved by a type I SPase after the second Ala residue (53). To determine the cleavage
site of GspA and the role of LepB1 and LepB2 in this process, we purified GspA by
affinity chromatography from A. oris strains lacking either gene or both and determined
the N-terminal sequences of the purified proteins by Edman degradation sequencing.
Because GspA is heavily glycosylated and its glycosylation sites are not known (50), we
expressed in these strains a GspA variant lacking its membrane-bound CWSS and
containing a His-tag at the C-terminus (Fig. 3-4A; pGspACWSS). Using this approach, we
could avoid the formation of high-molecular weight glycosylated GspA by forcing the
protein to be released as a monomer to facilitate detection of small changes in preprotein processing. After harvesting the cell-free culture supernatants of A. oris strains
expressing this construct by centrifugation and filtration, His-tagged proteins were
captured by Ni-NTA agarose and purified according to a published protocol (25). Purified
proteins were analyzed by SDS-PAGE, followed by Coomassie Blue and Periodic acidSchiff (PAS) staining to distinguish glycosylated proteins (see Materials and Methods). In
the WT strain, the predominant GspA band and a weaker band migrated below and
above the 37-kDa marker, respectively, in addition to the last one smeared between the
50- and 75-kDa markers by Coomassie Blue staining (Fig. 3-4B; left panel). As shown
previously, this predominant GspA species was negative for PAS staining, while
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Figure 3-4: Mapping the signal peptide cleavage site by Edman degradation. (A)
Shown is a graphic representation of GspA. The N-terminal sequence of GspA contains
a typical signal peptide comprised of a positively charged polar n-region, a hydrophobic
central region (h-region), and a c-region with the signal peptidase recognition motif AxA.
The arrowhead marks the predicted SPase I cleavage site. pGpsACWSS denotes a
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plasmid expressing a GspA variant, in which the CWSS is replaced by a six His-tag
(black circle). (B) His-tagged GspA proteins were purified from the culture medium of
indicated strains by affinity chromatography, separated by SDS-PAGE and visualized by
Coomassie Blue (~ 1.25 g of protein in all lanes) and Periodic acid-Schiff (PAS) (2.5 g
of protein) staining. Glycosylated horseradish peroxidase (HRP) and non-glycosylated
soybean trypsin inhibitor (STI) were used as positive and negative controls. Brackets
with numbers indicates glycosylated forms of GspA. (C) Indicated bands (vertical lines)
in B were subjected to Edman degradation. The N-terminal sequence of GspA was
deduced from the first 10 sequencing cycles (underline). Samples from the
lepB1/lepB2 mutant produced ragged N-terminal sequencing with the major sequence
shown. (D) Like GspA, FimA harbors a signal peptide with the conserved cleavage site
motif AXA. pFimACWSS represents a plasmid expressing a FimA molecule, in which the
CWSS is replaced by a six His-tag (black circle). (E) His-tagged FimA proteins were
purified from the culture medium of indicated strains by affinity chromatography,
separated by SDS-PAGE and stained by Coomassie Blue. (F) The purified proteins were
subjected to N-terminal sequencing. Underlines indicate the sequence resulted from first
10 sequencing cycles. The lepB2 mutant also produced ragged N-terminal sequencing
with the major sequence shown.
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some trace of PAS staining was detected with the smeary band (Fig. 3-4B; bracket 1). The
same phenotypes were observed in the lepB1 mutant; intriguingly, in the lepB2 mutant
a smeary band migrating around 37-kDa was positive for PAS staining (Fig. 3-4B; bracket
2), while the high molecular weight (HMW) band stained positive for PAS remained weakly
visible (Fig. 3-4B; bracket 1). Finally, in the double lepB1/B2 mutant a further-upshifted
band with positive PAS staining was detected. In addition, the HMW species of GspA
showed a slight increase in PAS staining (Fig. 3-4B; bracket 1, last lane). These results
indicate that glycosylation of GspA still occurs, albeit weakly, in the absence of the CWSS.
Together with the data presented in Fig. 3-3A, we conclude that neither the deletion of
lepB1 nor lepB2 affects GspA glycosylation.

If either SPase is sufficient to process GspA, the cleaved products in each deletion
mutant should contain the same N-terminal sequence. To determine if this is the case, we
excised the major GspA bands indicated in Fig. 3-4B for Edman sequencing. As shown in
Table 3-1, the first ten cycles of Edman degradation for GspA samples purified from the
WT, lepB1, and lepB2 strains revealed the matching sequence of GDSLAFKIAD (Fig.
3-4C), consistent with the predicted cleavage site between Ala (-1 position) and Gly (+1
position) (Fig. 3-4A). In contrast, the same analysis of GspA samples isolated from the
lepB1/B2 mutant produced a mixture of residues in the majority of the first 10 Edman
sequencing cycles (Table 3-1) indicative of multiple polypeptides present in these
samples; with the major polypeptide that has the sequence of LAGDSLAFKI (Fig. 3-4C).
The results indicated that both LepB1 and LepB2 are capable of cleaving the GspA signal
peptide. In the absence of both SPases, the GspA signal peptide might be proteolytically
degraded at different residues by unidentified protease(s).
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Table 3-1: Protein sequencing of GspA proteins purified from four A. oris strains
by Edman degradation
Sequencing
Cycle

a Two

Residue (pmol)
MG1

∆lepB1

∆lepB2

∆lepB1/∆lepB2 a

1

G (4.761)

G (13.250)

G (7.833)

L (3.150); A (3.665)

2

D (4.438)

D (13.830)

D (8.280)

A (3.887)

3

S (2.529)

S (5.692)

S (4.623)

G (2.938); P (1.390)

4

L (3.972)

L (10.650)

L (6.026)

D (2.962); A (2.836)

5

A (4.082)

A (11.050)

A (6.184)

S (1.774)

6

F (2.913)

F (8.309)

F (5.394)

L (3.162)

7

K (3.882)

K (10.280)

K (5.761)

A (4.124); G (2.501)

8

I (2.661)

I (8.125)

I (4.958)

F (2.520); D (2.494)

9

A (3.427)

A (9.922)

A (5.492)

K (2.520); S (1.729)

10

D (2.794)

D (7.996)

D (5.265)

I (1.875); L (2.144)

major residues were detected in the majority of the first 10 sequencing cycles.
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LepB2 is required for pilus assembly – As previously mentioned, in addition to GspA
and 13 other cell wall anchored proteins (25), the A. oris MG1 strain expresses 4 pilus
proteins FimP/Q and FimA/B, which constitute type 1 and type 2 fimbriae, respectively
(18,79,84). We asked if the function of the two SPases is extended to these LPXTGcontaining pilus proteins. Using the same approach described for GspA, whereby the
CWSS of FimA was replaced by a His-tag (Fig. 3-4D), we purified secreted FimA
proteins from the culture medium and analyzed them by SDS-PAGE and Edman
degradation. While the FimA proteins isolated from the WT and lepB1 strains migrated
with the same mobility by SDS-PAGE, the FimA proteins isolated from the lepB2
mutant migrated slightly slower as compared to the first two (Fig. 3-4E). Consistently,
Edman degradation revealed the same sequence of TETPNYGNIK in the first two
samples, supportive of the cleavage site between Ala (-1) and Thr (+1) (Fig. 3-4D),
whereas the last one had ragged sequences, with the major species of AVATETPNYG
(Fig. 3-4F and Table 3-2). The results indicate that LepB1 is not required for proper
cleavage of the FimA signal peptide and that LepB2 is essential for FimA pre-protein
processing.
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Table 3-2: Protein sequencing of FimA proteins purified from four A. oris strains
by Edman degradation
Sequencing
Cycle

Residue (pmol)
MG1

∆lepB1

∆lepB2 a

1

T (8.363)

T (2.341); G (1.394)

A (10.082); T (8.999); G (70.840);

2

E (6.034)

E (1.391)

V (6.512); E (6.271); L (6.009)

3

T (7.885)

T (2.137)

A (10.563); T (9.934)

4

P (6.338)

P (1.786)

T (10.321); P (8.828)

5

N (4.784)

N (1.467)

E (5.881); N (4.545)

6

Y (5.789)

Y (1.512)

T (11.027); A (9.149); Y (5.218)

7

G (5.246)

G (2.061)

P (7.555); G (11.852); V (6.863)

8

N (4.597)

N (1.412)

N (5.679); A (9.687)

9

I (4.777)

I (1.771)

I (6.770); Y (4.509)

10

K (5.922)

K (1.133)

K (6.659); G (12.054); E (5.618)

a Multiple

residues were detected in each of the first 10 sequencing cycles.
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We next investigated the impact of LepB2-mediated cleavage of FimA precursors
by examining pilus assembly on the bacterial cell surface by IEM. A. oris cells were
immobilized on nickel grids, washed and stained with antibodies against FimA (-FimA)
and then reacted with secondary IgG antibodies conjugated to gold particles. Samples
were then stained with 1% uranyl acetate and viewed by an electron microscope. As
expected, FimA labeled pili were abundant on the surface of wild-type cells, but absent
in a mutant lacking fimA (Fig. 3-5A & 3-5B). Note that visible unstained pili in the fimA
mutant were FimP pili (79). While the deletion of lepB1 did not affect FimA pilus
assembly, deletion of lepB2 severely affected assembly (compare Fig. 3-5C & 3-5D).
Ectopic expression of LepB2 in the lepB2 mutant rescued this assembly defect to the
wild-type levels (Fig. 3-5E). To examine if LepB2 is required for the assembly process of
tip fimbrial proteins, we quantified the protein level of FimB and CafA on the bacterial
surface by whole-cell ELISA. Consistent with the above results, the lepB2 mutant
displayed drastic reductions in FimB and CafA signal the lepB1 mutant exhibited wildtype levels of both pilus tip proteins (Fig. 3-6).

To determine if LepB2 also acts on type 1 fimbriae, we analyzed pilus assembly
using IEM with antibodies against the fimbrial shaft protein FimP (-FimP). As shown in
Fig. 3-5F-J, the FimP phenotypes mirrored those of FimA presented above. Altogether,
the results indicated that LepB2 is specifically utilized for processing of pilus precursors
in A. oris.
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Figure 3-5: The signal peptidase LepB2 is required for pilus assembly. A. oris cells
were immobilized on nickel grids, reacted with the specific antiserum against the type 2
major pilin subunit, FimA (α-FimA) (A – E) or the type 1 major pilin subunit FimP (α-FimP)
(F – J) followed by goat anti-rabbit IgG conjugated to 12-nm gold particles, and stained
with 1.0% uranyl acetate. Samples were viewed by transmission electron microscopy.
Scale bars, 0.2 μm.
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Figure 3-6: Requirement of LepB2 for surface expression of tip pilins. The
presence of FimB (A) and CafA (B) on the bacterial cell surface was analyzed by whole
cell ELISA with specific antiboides to FimB and CafA, respectively. The absorbance
values, as compared to those of corresponding mutants as background, were
determined from at least two independent experiments performed in triplicate. Error bars
represent standard deviations. Asterisks (*) indicate P-values of 0.02 (A) and 0.03 (B);
all were determined using the paired, two-tailed t-test with Prism GraphPad.
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Requirement of the conserved catalytic dyad for LepB2 activity – Bacterial type 1
SPases utilize a conserved Ser-Lys catalytic dyad present within the conserved Box B
and Box D, respectively, for their proteolytic activities (60). Our sequence alignment of
LepB1 and LepB2 with many other Gram-positive signal peptidases revealed the
conservation of this catalytic dyad (Fig. 3-7A). In LepB2, Ser is located at position 101
and Lys at 169. To determine if these residues are indeed required for LepB2 activity,
we generated recombinant plasmids expressing LepB2 with alanine substitutions at
S101 or K169. The resulting plasmids were introduced into the lepB2 mutant and the
effects of these mutations on pilus assembly were analyzed by immunoblotting and EM.
By Western blot analysis, we observed high molecular weight species of FimP and FimA
indicative of pilus polymers (denoted as P) in the culture medium (S) and cell wall (W)
fractions of wild-type cells (Fig. 3-7B & 3-7C; first two lanes), as previously reported (84).
While deletion of lepB1 did not affect pilus assembly (Fig. 3-7B & 3-7C; next two lanes),
deletion of lepB2 greatly reduced pilus polymers and increased the accumulation of
LMW products, presumably degradation products, in the membrane as well as their
secretion into the culture medium (Fig. 3-7B & 3-7C; lanes lepB2). The defects of this
mutant were rescued by ectopic expression of lepB2 (Fig. 3-7B & 3-7C; lanes
lepB2/pLepB2). As expected, alanine substitutions of S101 and K169 resulted in the
same defects as deletion of lepB2 (Fig. 3-7B & 3-7C; last 4 lanes). The effects of the
catalytic dyad mutations on pilus assembly were also confirmed by negative-staining EM
(data not shown). Thus, LepB2 contains a canonical catalytic dyad present in type I
signal peptidase enzymes, and this dyad is critical for LepB2 activity.
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Figure 3-7: The Ser-Lys catalytic dyad of LepB2 is necessary for pilus assembly.
(A) Multiple sequence alignment of type 1 SPases from A. oris (LepB1 and LepB2),
Mycobacterium leprae (LepB), Streptomyces coelicolor (Sip1), Bacillus anthracis (SipS),
Bacillus subtilis (SipS), and Streptococcus pneumoniae (Spi) was performed using
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CLUSTAL W (112). The conserved Box B and Box D, which contain the catalytic Ser
and Lys residues (highlighted in black), respectively, are shown. Numbers indicate Ser
and Lys positions in A. oris LepB2. (B) Supernatant (S) and cell wall (W) fractions were
collected from MG1 and its isogenic derivatives. Equivalent protein samples were
subjected to immunoblotting with α-FimP. (C) The same samples in B were
immunoblotted with α-FimA. The positions of fimbrial monomer (M), HMW polymers (P),
and molecular mass markers are indicated.
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Because LepB2 is required for pilus assembly and type 2 fimbriae are involved in
polymicrobial interactions (or coaggregation) and biofilm formation, we then examined if
LepB2 is also important for these processes. To test for polymicrobial interactions,
Actinomyces cells were mixed with Streptococcus oralis in equal numbers and
coaggregation was determined both visually (113) and quantitatively as previously
reported (93). As shown in Fig. 3-8A & 3-8B, Actinomyces coaggregation with S. oralis
was dependent on CafA as deletion of cafA abrogated this interaction, consistent with
our previous report (25). Compared to the parental MG1 strain, the lepB1 mutant did not
display any noticeable defect in coaggregation. In contrast, deletion of lepB2 significantly
reduced bacterial coaggregation; this defect was rescued by overexpressing wild-type
LepB2 from a plasmid, but not from the catalytically inactive LepB2 variants, i.e. S101A
or K169A. Finally, the ability of the LepB2 mutants to form biofilms was evaluated using
an established protocol (93), whereby Actinomyces biofilms were cultivated in the
presence of 1% sucrose and quantified by staining with crystal violet (see Methods).
Unlike the lepB1 mutant, which produced biofilms at the wild-type level, the lepB2
mutant was unable to form biofilms. The biofilm defect of the lepB2 mutant was restored
when wild-type LepB2 was expressed ectopically, but not with the S101A or K169A
mutant (Fig. 3-8C and 3-8D). Altogether, the results support the notion that LepB2 is the
signal peptidase specific for LPXTG-containing pilus proteins in A. oris.
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Figure 3-8: Requirement of LepB2 for polymicrobial interactions and biofilm
formation. The parental A. oris MG1 strain and its variants were examined for their
ability to interact with Streptococcus oralis. Coaggregation was scored visually (A) or
quantitatively by optical density (B). To cultivate biofilms, Actinomyces cells were grown
in microtiter plates in the presence of 1% sucrose at 37oC with 5% CO2. Generated
biofilms were stained with crystal violet (C) and subsequently quantified by measuring
absorbance at 580 nm (D). The values are expressed as averages of three independent
experiments performed in triplicate. Symbols *, **, and *** indicate p values of 0.05, 0.01,
and 0.005, respectively; all determined using the paired, two-tailed t-test with Prism
GraphPad.
71

Discussion
We recently reported that the signal peptidase LepB2 is a genetic suppressor of srtA
essentiality in A. oris, a lethal phenotype associated with glyco-stress caused by
accumulation of the glycosylated protein GspA in the cytoplasmic membrane when SrtA
is disabled (50). The suppressor was found when we recovered a viable srtA-deleted
mutant with the Tn5 transposon inserted into the lepB2 gene (50). In this report, we
confirmed the suppression phenotype of lepB2 by deleting chromosomal srtA in a strain
already devoid of lepB2 (Fig. 3-1). It is important to note that deletion of srtA in the
absence of gspA is also non-lethal (50) suggesting that LepB2 acts on the GspA
glycosylation pathway. Indeed, in the lepB2/srtA double mutant, GspA glycosylation
was severely defective (Fig. 3-3) unlike the phenotype of srtA depletion, which does not
affect GspA glycosylation (50). lepB2 is part of a gene locus that encodes another signal
peptidase gene, lepB1 (Fig. 3-1A). This raises a question of redundancy as multiple
copies of SPases are typically present in a single species of Gram-positive bacteria (60).

To address this question, we mapped the cleavage site of the GspA signal
peptide by Edman degradation. Because GspA is heavily glycosylated leading to a
smeared migration pattern on SDS-PAGE (Fig. 3-3A), detecting the cleavage of the
GspA signal peptide was challenging. To circumvent this problem, we constructed a
GspA molecule lacking its CWSS (denoted as GspACWSS), which caused it to be
secreted into the extracellular milieu with less chance of glycosylation. To our surprise,
the GspACWSS precursor was properly processed when expressed in the absence of
LepB1 or LepB2 (Fig. 3-4B & 3-4C). Especially when considering that LepB2 is linked to
GspA glycosylation. The results support the idea that both SPases are capable of
cleaving the GspA signal peptide. This is consistent with the observation that in the
absence of both lepB1 and lepB2 the GspA signal peptide was not properly processed
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(Fig. 3-4C). It is intriguing, however, that the glycosylation level of GspA detected in the
cell wall fraction of this double mutant was comparable to that of the parental and single
deletion strains (Fig. 3-3A). This seems contradictory to a general belief that processing
of the signal peptide is a prerequisite for protein maturation (40). We speculate that
GspA glycosylation occurs immediately as the protein precursors emerge from the Sec
translocon. This is in line with the “Pilusosome Hypothesis” that sortase and its
substrates are in close proximity with a protein secretion machine for efficient assembly
(114). It is also possible that in the absence of the two SPases aberrant cleavage of the
protein precursors, probably by membrane-bound protease(s), is sufficient to release the
polypeptides from the secretion machine for sortase and glycosyltransferases to be able
to perform their functions.

While both LepB1 and LepB2 are capable of processing GspA, we demonstrated
that only LepB2 is specific for cleavage of fimbrillin signal peptides. Using the major
fimbrillin shaft FimA as an experimental model, we showed by N-terminal sequencing
that cleavage of the FimA signal peptide depends on LepB2 (Fig. 3-4 D-F). In the
absence of the cognate signal peptidase LepB2, the FimA signal peptide was
proteolytically cleaved producing ragged polypeptides (Table 3-2). Unlike GspA, this
failure of signal peptide cleavage severely affected fimbrial assembly (Fig. 3-5).
Consequently, the ability of this mutant strain to interact with oral streptococci and to
form biofilm is significantly hindered (Fig. 3-8). LepB2 function is not limited to type 2
fimbriae, as the lepB2 mutant also fails to assembly type 1 fimbriae with FimP as the
fimbrial shaft; in contrast, LepB1 is dispensable for these processes (Fig. 3-5, 3-6 and 37).

The notion that a signal peptidase is involved in pilus formation has been
previously reported with the signal peptidase-like protein SipA in the Gram-positive
73

pathogen Streptococcus pyogenes (115). SipA is expressed by the gene locus that
encodes the T3 pilin components in many strains of S. pyogenes (115). Although it has
the same core fold as the type I SPase of Escherichia coli (116), it lacks the catalytic Ser
and Lys residues typical of type I SPases (117) (Fig. 3-7A). In place of Ser and Lys are
Asp and Gly, but they do not play any role in signal peptidase activity nor cleavage of T3
pre-pilins (117). Unlike SipA, LepB2 contains a canonical catalytic dyad with the
conserved S101 and K169 (Fig 3-7A). Alanine substitution of these residues abrogates
pilus assembly as well as biofilm formation (Fig. 3-7 and 3-8). Altogether, it is clear that
LepB2 is a type I SPase, which may serve as the prototype of type I SPases specific for
pilus assembly in Gram-positive bacteria.
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CHAPTER IV
A Phosphotransferase LCP Enzyme Mediates Glycosylation of a
Gram-positive Cell Wall Anchored Protein
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Introduction

Glycopolymers such as wall teichoic acids (WTAs) displayed on the cell envelope of
Gram-positive bacteria play critical roles in cell physiology by modulating
immunogenicity, host and bacterial surface interactions, protein stability, cell division and
affinity for charged molecules including antimicrobial peptides and cations
(38,39,118,119). WTAs are polyol repeats ending in a disaccharide linkage unit attached
to the C6 hydroxyl group of N-acetyl muramic acid (MurNAc) of bacterial peptidoglycan
via a phosphodiester bond (120). Attachment of WTAs to the anchor molecules of the
cell envelope requires LytR-CpsA-Psr (LCP) family enzymes widespread in Grampositive bacteria (121). The first crystal structure of an LCP enzyme was CpsA2 from
Streptococcus pneumoniae. The enzyme contains a hydrophobic tunnel capped with
surface exposed catalytic arginine residues, and of theseboth features that are essential
for functionality (44). Serendipitously, the CpsA2 structure co-crystalized with octaprenylpyrophosphate (oprPP), where the isoprenyl tail is nestled within the hydrophobic pocket
and the pyrophosphate head group interacted with the surface exposed arginine
residues. In the case of WTAs, LCP proteins catalyze the formation of a phosphodiester
bond to link the glycan to the MurNAc of the cell wall. A pyrophosphatase reaction
removes the glycan from the lipid donor molecule (122). It has been previously
demonstrated that S. pneumoniae CpsA2 and Corynebacterium glutamicum LcpA
possess in vitro pyrophosphatase activity and this is likely a characteristic of most LCP
enzymes that mediate phosphotransfer (44,47,97).

An LCP protein has also been identified in the Gram-positive actinobacterium
Actinomyces oris, a key colonizer of the oral cavity that plays an important role in the
development of oral biofilms or dental plaque (2). The identification of A. oris LcpA that is
linked to the glycosylation of the cell wall anchored protein GspA was revealed by an
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unbiased transposon mutagenesis screen. Deletions of both lcpA and gspA were shown
to suppress the essentiality of the housekeeping sortase srtA. Additionally, the adjacent
encoding of lcpA and gspA genes in A. oris indicates that their protein products are
functionally linked (50). GspA harbors a typical C-terminal cell wall sorting signal (CWS),
which is recognized by sortase enzymes for covalent attachment to peptidoglycan via an
LPXTG motif within the CWSS (51). Biochemical evidence indicates that GspA is highly
glycosylated and this glycosylation requires LcpA. A mutant strain lacking lcpA no longer
produces high molecular mass glycopolymers of GspA and concomitantly accumulated
intermediate forms (50). A model for srtA essentiality involving both GspA and LcpA has
been proposed: as GspA is translocated across the cytoplasmic membrane by the Sec
machine, it is glycosylated by LcpA with the glycan chain synthesized by a separate
pathway and subsequently anchored to the cell wall by the housekeeping sortase SrtA
(50). In the absence of srtA, glycosylated GspA accumulates in the membrane leading to
toxic glycol-stress. Consistent with this model, genetic disruption of srtA in the absence
of lcpA, gspA, or a GspA mutant devoid of the membrane anchored CWSS results in
viable cell types (50).

While the exact nature and composition of the GspA glycans remain to be
biochemically determined, A. oris LcpA represents the first example of an LCP enzyme
that modifies a cell wall anchored protein substrate. Here, we present a high resolution
crystal structure of A. oris LcpA revealing conserved features of known LCP enzymes
and unique characteristics that may be typical of actinobacterial LCP proteins. Further
biochemical characterization provides evidence that not only does LcpA possess
pyrophosphatase activity but it also functions as a phosphotransferase that catalyzes
glycosylation of the cell wall anchored protein GspA.
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Results
LcpA is required for GspA glycosylation. As previously mentioned, a screen for
sortase SrtA suppressors identified an LCP homolog (ana_1292) hereafter named lcpA
(50), which is located immediately downstream of gspA (Fig. 4-1A), which is another
suppressor of srtA lethality (50). In addition to LcpA, A. oris MG1 encodes three
additional proteins with LCP domains. ana_0299, hereafter called lcpB, is adjacent to
two conserved genes (Fig. 4-1A) coding for a UDP-N-acetyl-D-mannosaminuronic acid
dehydrogenase (ana_0300) and a homolog of glycosyl/glycerophosphate transferase
TagF, which has previously been implicated in the wall teichoic acid (WTA) synthesis of
Staphylococcus epidermidis (123). ana_1577 (lcpC) and ana_1578 (lcpD) appear to
reside in the same transcriptional unit (Fig. 4-1A). Because LcpA has been linked to
GspA glycosylation (123), we examined if genetic disruption of LcpB, LcpC, and LcpD
affects this process, although all three were not identified from the original suppressor
screen. We obtained mutations in lcpB and lcpD, but we were unable to generate a
deletion mutation of the lcpC gene after several attempts suggesting lcpC is an essential
gene. A triple mutation (lcp∆3) of lcpA, lcpB, and lcpD was also obtained.

To analyze LcpA-mediated glycosylation, cell cultures of A. oris MG1 and these
mutant strains were grown to mid-log phase, normalized by optical density and
subjected to cell fractionation, as previous described (50). Protein samples from the
culture medium (S) and cell wall (W) fractions were analyzed by western blotting with a
specific antibody against GspA (α-GspA). As reported before (123), the MG1 strain (WT)
produced a high molecular-mass species of GspA with glycan polymers, i.e. GspAHMM,
detected mostly in the cell wall fractions (Fig. 4-1B, lanes WT). Deletion of lcpA
abrogated formation of GspAHMM resulting in accumulation of a low molecular weight
species of GspA termed GspALMM. GspALMM migrates near the 37-kDa marker, although
the GspA monomer (GspAM; arrowhead) migrates near the 25-kDa marker (Fig. 4-1B,
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lanes ∆lcpA). The single mutant strains ∆lcpB and ∆lcpD displayed no significant defects
in formation of GspAHMM (Fig. 4-1B, lanes ∆lcpB and ∆lcpD), whereas the triple mutant
lcp∆3 failed to produce GspAHMM phenocopying the lcpA mutant; this defect was rescued
by ectopic expression of lcpA in the lcp∆3 mutant (Fig. 4-1B, last 4 lanes). To determine
if deletion of lcpA affects cell morphology and pilus assembly, the parental and lcpA
mutant strains were examined by electron microscopy, whereby bacterial cells,
immobilized on carbon-coated nickel grids, were stained with 1% uranyl acetate prior to
viewing with an electron microscope. As shown in Fig. 4-1C-D, both strains displayed
similar cell morphology and pilus assembly phenotypes. Altogether, the results support
that LcpA is necessary and sufficient for the production of GspAHMM and suggest that
GspALMM might represent an intermediate form of the glycoprotein GspAHMM.
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Figure 4-1: LcpA is solely responsible for GspA glycosylation. (A) Presented are
gene clusters that encode four LCP proteins (LcpA-D) with numbers indicating the
nucleotide positions of lcp genes. (B) A. oris cells of indicated strains grown to early log
phase were subjected to cell fractionation. Culture medium (S) and cell wall (W) fractions
were analyzed by immunoblotting with specific antibodies against GspA. High molecular
mass (HMM) and low molecular mass (LMM) species of GspA, GspA monomer (M), and
molecular mass markers are indicated. (C & D) A. oris cells were immobilized on nickel
grids, stained with 1% uranyl acetate prior to viewing with an electron microscope. Scale
bar represents 0.5 µm.
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(Note: Portions of the writing in the following section is credited to Brendan Amer,
who performed the X-ray crystallography, and was used with permission.)

X-ray structure of LcpA from Actinomyces oris. To obtain insight into how LcpA
glycosylates GspA we first determined the molecular structure of the LcpA enzyme. An
inspection of its primary sequence reveals a proposed tripartite structure: (i) residues 154 presumably reside in the cytoplasm and are predicated to adopt helical secondary
structure, (ii) residues 55-77 are non-polar and likely form a single transmembrane helix
(TM), and (iii) residues 78-370 presumably reside on the extracellular surface and share
primary sequence homology to LCP-type enzymes (Pfam family PF03816). The
structure of the extracellular LCP domain (rLcpA, residues 78-370) was solved at 2.5-Å
resolution. Electron density was observed for residues 79-106 and 126-368, which form
a single domain that adopts an α–β–α architecture. A seven‐stranded anti-parallel β‐
sheet forms the core of the protein with a total of eight α‐helices flanking the β-sheet on
both of its faces forming a hydrophobic tunnel (Fig. 4-2A). The tunnel is ~23 Å in length
and is lined by residues located on the central β-sheet, helices H5, H6 and H7. The
tunnel varies in width from ~6 to 14 Å and is widest in the core of the protein. The
surface of the tunnel contains many non-polar residues consistent with it interacting with
lipid substrates. Interestingly, during refinement, an additional electron density was
observed near the exit point of the tunnel defined by helices H6 and H7 indicating that a
ligand was bound. However, it was not possible to conclusively define the identity of this
ligand using MALDI-TOF mass spectrometry and modeling the ligand as a phosphateisoprenoid molecule or other membrane-associated lipid yielded poor refinement
statistics. The best match to the data was obtained by modeling the ligand as a PEG4000 molecule that was used as a precipitant during crystallization. This ligand is bound
with 50% occupancy and defines the exit point for the tunnel distal to the active site.
The presence of a hydrophobic tunnel leading into the active site suggests that LcpA
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could bind a lipid-linked glycan donor substrate similar to other members of the LCP
superfamily (44).

Members of the LCP superfamily contain conserved arginine residues, which are
thought to mediate a phosphotransfer reaction that attaches glycopolymers to acceptors
(122). In A. oris LcpA, R128, R149, and R266 are conserved residues that cluster
together within a surface exposed pocket (Fig 4-2A and Fig. 4-2B, shown in red). One
surface of this exposed active site is formed by residues in strand β3 and helix H1, while
the top and side of the pocket is formed by helix H4 and H5, respectively, packing
against the core β-sheet. R128 and R149 in the pocket are positioned towards the
surface and located in strands B β3 and β4/ β5 loop, respectively. Helix H5 spans the
length of the protein and contains the third conserved active arginine (R266), which is
located closer to the body of the enzyme where the pocket narrows. Electron density is
observed between the guanidino sidechains of R128 and R149 and the modeled
phosphate atom. The hydrophobic tunnel leads from this conserved site to the opposite
face of the protein structure.

Intriguingly, unlike other LCP enzymes, LcpA contains a disulfide bond formed
between residues C179 and C365 linking the C-terminus to α-helix H2 (Fig. 4-2C). This
disulfide is presumably stabilizing, since it persists despite the presence of a reducing
agent in the protein buffer used in the final purification step. The cysteine residues are
also conserved in other LCP homologs present in Actinobacteria.

The structure of rLcpA is similar to that of previously reported LCP enzymes that
attach polymers to the cell wall and is most closely related to the YwtF (TagT) enzyme
from Bacillus subtilis based on a DALI analysis with a Z-score of 21.8 (PDB: 4DE9 (46));
the backbone atoms can be superimposed with a root-mean-square deviation (RMSD) of
2.5Å (Fig. 4-2D). The structural conservation and presence of arginine residues in the
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surface exposed pocket prompted us to investigate functional similarities to TagT related
to GspA glycosylation.
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Figure 4-2: Crystal structure of A. oris LcpA and structural requirements for
glycosylation activity. (A) The structure of the extracellular LCP domain (residues 78370) was determined to 2.5-Å resolution. The proposed catalytic Arg residues are shown
as sticks and colored red, and the cysteine residues participating in the disulfide bond
are shown in yellow. (B) Presented is a detailed view of the LcpA active site with the
conserved catalytic arginine residues (R128, R149, and R266) shown in red. (C) Shown
is a close-up view of the disulfide bond that links the C-terminus via C365 to the second
α-helix via C179 present in the LCP extracellular domain. (D) The LcpA structure (light
green) is superimposed with the Bacillus subtilis YwtF (TagT) (PBD: 4DE9) (magenta).
(E) Protein samples of indicated strains were prepared as described in Fig. 1B and
analyzed by immunoblotting with anti-GspA. (F) Protein samples from the membrane
fractions in (E) were immunoblotted with antibodies against LcpA. A membrane protein,
MdbA, was used as a control. Molecular mass markers in kDa are shown. Note:
Crystallization, structural determination and modeling were performed by Brendan
Amer and Jason Gosschalk and used with permission.
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The conserved arginine residues in LcpA are required for glycosylation activity.
As presented above, LcpA is required for glycosylation of GspA (Fig. 4-1B) and LcpA
contains conserved arginine residues (R128, R149 and R266) (Fig. 4-2B). Conserved
Arg residues have been implicated in LCP activity by interacting with the pyrophosphate
of the lipid-linked glycan donor (44). To determine whether these Arg residues affect the
glycosylation activity of A. oris LcpA, we generated alanine-substitution mutants of these
arginine residues using pLcpA as a template (Fig. 4-2E). Plasmids expressing mutant
proteins were introduced into the ∆lcpA mutant and expression of LcpA proteins was
determined by immunoblotting membrane lysates of various strains with specific
antibodies against LcpA (α-LcpA) or with α-MdbA, to detect MdbA as a control for the
membrane bound protein (62). As expected, LcpA was detected in the parental strain
and absent from the ∆lcpA mutant (Fig. 4-2E, first two lanes). Complementation of the
∆lcpA mutant with a multi-copy plasmid enhanced LcpA production as compared to the
WT strain (Fig. 4-2E, lane LcpA). Mutations of the three Arg residues did not affect the
stability of mutant proteins as compared to ectopically expressed wild-type LcpA (Fig. 42E, last 3 lanes). We then examined GspA glycosylation by Western blotting the
supernatant and cell wall fractions as described in Fig. 4-1B. Interestingly, the LcpAR128A mutant was able to produce GspAHMM at the level comparable to that of the WT
strain and the rescued strain ∆lcpA/LcpA, whereas the LcpA-R149A and LcpA-R266A
mutants were defective in glycosylation of GspA phenocopying the ∆lcpA mutant (Fig. 42F). Altogether, the results support that the R149 and R266 residues are essential for
the glycosylation activity of LcpA.
The disulfide bond in A. oris LcpA is required for protein stability. A. oris LcpA has
a stable disulfide bond (Fig. 4-2C), and it appears that the disulfide linkage is a
conserved feature in Actinobacterial LCP proteins. To determine the role of the disulfide
bond in LcpA stability and glycosylation activity, we generated alanine-substitution
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mutants of either one (C365) or both Cys residues (C179 and C365). Membrane
fractions of the parental and mutant strains were immunoblotted with α-LcpA as
described previously. Enhanced signal of LcpA was observed in a strain expressing
LcpA from a plasmid, as compared to the parental strain (Fig. 4-3A, first 3 lanes).
However, no LcpA signal was detected in the membrane of strains expressing LcpA with
C365A or C179A/C365A mutation (Fig. 4-3A, last 2 lanes) suggesting that the disulfide
bond formed by C179 and C365 is required for stability of LcpA.

To ensure the protein production defect above was not due to the lack of lcpA
transcription, we collected mRNA in these strains and used reverse transcription PCR
(RT-PCR) to amplify a 196-bp region specific to the lcpA gene. In the WT strain, the lcpA
transcript was only detected when reverse transcriptase (RT) was added, with lcpA
amplified from genomic DNA (g) used as a control for the length and specificity of the
amplicon (Fig. 4-3B, lanes WT). As expected, no lcpA transcript was detected in the lcpA
mutant (Fig. 4-3B, lanes ∆lcpA), while the transcript levels of lcpA expressed from these
recombinant plasmids were comparable to the lcpA level in the WT strain (Fig. 4-3B,
remaining lanes). Altogether, the results suggest that in the absence of the disulfide
bond there is a defect in LcpA protein stability and is not due to lack of gene expression.

We next examined if mutations of these cysteine residues affect LcpA
glycosylation activity by immunoblotting the culture medium and cell wall fractions of the
same set of strains, according to the procedure described in Fig. 4-2F. Surprisingly,
strains expressing LcpA with C365A or C179A/C365A mutation produced GspAHMM,
albeit less abundant as compared to the WT and rescued strains with accumulation of
the intermediate GspALMM unlike the aforementioned strains (Fig. 4-3C). The data
strongly indicate that the disulfide bond is necessary for full activity of LcpA.
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We previously reported that disulfide bond formation in A. oris requires the
activity of a membrane bound thiol-disulfide oxidoreductase named MdbA (62), and
reactivation of MdbA involves another oxidoreductase called VKOR (124,125). A mutant
strain of mdbA is not possible, so because vkor contributes to, but is not required for
oxidative protein folding (62), we examined if LcpA stability is affected in the vkor
mutant. To test this possibility, the parent, its isogenic ∆vkor mutant, and rescued strains
were subjected to cell fractionation. To determine if deletion of vkor affects LcpA
expression, protoplast fractions were analyzed by Western blotting with α-LcpA; protein
levels were quantified by densitometry from four independent experiments with loading
controls from the same blots stained by Coomassie. As compared to the WT and
rescued strains, the ∆vkor mutant produced significantly less LcpA (Fig. 4-3D-E). As a
control, the protein level of the housekeeping sortase SrtA remained the same in three
strains (Fig. 4-3D). When the culture medium and cell wall fractions were immunoblotted
with anti-GspA there were no significant defects in GspA glycosylation. In the ∆vkor
mutant GspALMM species accumulated in this strain as compared to the WT and
complementing strains (Fig. 4-3F). Altogether, the results support that disulfide bond
formation is critical for LcpA stability and this oxidative protein folding is mediated by the
major oxidoreductase machinery MdbA and VKOR as previously reported (62).
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Figure 4-3: The disulfide bond C179-C365 is required for LcpA stability. (A)
Immunoblotting of the membrane fractions of indicated strains were performed as
described in Fig. 4-2F with anti-MdbA used for the control membrane protein MdbA. (B)
Expression of lcpA in indicated strains was analyzed by RT-PCR using primers specific
for a 196-bp region of lcpA. A. oris MG1 genomic DNA (gDNA) was used as controls for
length and specificity. (+) and (-) indicate the presence or absence of reverse
transcriptase (RT). (C) Protein samples from the indicated strains were prepared and
analyzed by immunoblotting as described in Fig. 4-2F. (D) Shown is a representative
Western blot of protoplast fractions of the MG1 strain (WT), the ∆vkor mutant, and this
mutant expressing VKOR from a plasmid. LcpA is marked with an arrow, whereas a non88

specific band is shown as an asterisk (*); an arrowhead for a loading control band from
the immunoblotted membrane stained with Coomassie blue. The membrane-bound
protein SrtA serves as a control. (E) Relative steady state stability of LcpA was
determined by comparing the relative intensity of the LcpA bands in (D), which were
normalized against the loading control band. The relative intensity of the wild-type LcpA
bands was set to 1. Error bars represent standard deviation (SD) of four independent
replicates. (F) The culture medium and cell wall fractions of the indicated strains were
analyzed by immunoblotting as described in panel C.
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LcpA exhibits pyrophosphatase activity in vitro. LCP enzymes studied to date
possess pyrophosphatase activity, i.e., they catalyze the hydrolysis of pyrophosphate
bonds. For example, the LCP enzyme TagT from B. subtilis showing that the enzyme
exhibits pyrophosphatase activity in vitro as do LCP proteins from Mycobacterium
tuberculosis and Corynebacterium glutamicum (44,47,97). In LCP enzymes interaction
of the arginine residues with the pyrophosphate is necessary for pyrophosphatase
activity. We modeled an Opr-PP molecule into the LcpA hydrophobic pocket. This model
was created using electron density of the modeled phosphate ion to place the phosphate
head groups of Opr-PP and the electron density used to model PEG4000 to model the
lipid component of the Opr-PP polyprenyl (Fig. 4-4A). Indeed, R149 and R266 interact
with the pyrophosphate head group according to the model. To test for pyrophosphatase
activity of A. oris LcpA, we utilized an in vitro assay with a diphosphate mimetic
substrate, farnesyl pyrophosphate (FPP) and rLcpA and its mutant derivatives purified
from E. coli. Pyrophosphatase activity of LcpA proteins was determined by quantitatively
measuring inorganic phosphate (Pi) release from FPP (Fig. 4-4B). It was found that
rLcpA was able to hydrolyze FPP exhibiting a Vmax of 1.509 ± 0.077 nM hr-1 and Km of
15.16 ± 3.656 µM (Fig. 4-4C). The saturating substrate concentration occurred at an
enzyme-to-substrate ratio of approximately 1:30 (Fig. 4-4C).
We then examined if mutations of the catalytic residue R149 and disulfide bond
C179/C365 affect the pyrophosphatase activity of LCP using the above assay with the
saturating substrate concentration. As expected, the LcpA enzyme and FPP contained
little to no background Pi (Fig. 4-4D, first 2 columns). Compared to the wild-type rLcpA
enzyme, alanine-substitution of R149 in rLcpA abrogated the enzymatic
pyrophosphatase activity (Fig. 4-4D, compare lane 4 to lane 3) further confirming the
essential role of this catalytic residue. Consistent with the in vivo results above, the
rLcpA protein lacking the disulfide bond C179-C365 exhibited significantly reduced
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pyrophosphatase activity, approximately 3-fold less than the wild-type (Fig. 4-4D, last
column). Altogether, the results indicate that LcpA possesses pyrophosphatase activity
and that the disulfide bond C179-C365 plays in important role in maintaining the full
activity of LcpA.
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Figure 4-4: LcpA exhibits pyrophosphatase activity. (A) Octaprenyl-pyrophosphate
(oprPP) bound to A. oris LcpA was modeled with the prenol chain shown in turquoise
and the pyrophosphate in orange. Potential interactions of Arg residues (red) with the
pyrophosphate head group are presented. (B) Presented is the hydrolysis reaction of
farnesyl pyrophosphate (FPP) by LCP enzymes resulting in formation of farnesyl
monophosphate (FMP) and inorganic phosphate (Pi, orange). (C) 3 µM of recombinant
LcpA was incubated with increasing concentrations of FPP for 24 h at 30oC. Released Pi
was detected by a fluorescent method and quantified from three biological replicates; the
Vmax and Km values were calculated using the Michalis-Menten equation in Prism
GraphPad, and error bars represent standard error of the mean (SEM) fit by nonlinear
regression. (D) Pyrophosphatase activity at saturating substrate concentrations (1:30) of
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recombinant LcpA and mutant derivatives, LcpAR149A and LcpAC179A-C365A, was
determined as described in (C) with sole LcpA and FPP included as controls. The results
were derived from three independent experiments performed in triplicate with phosphate
standards performed in parallel. Error bars represent SEM, and statistical analysis with a
one-tailed Mann-Whitney-Wilcoxon test was determined using Prism GraphPad. The
asterisk (*) indicates p-values of 0.0383 and 0.0500 for reactions with R149A and
C179A-C365A enzymes, respectively; nd, not detected. Note: Modeling of LcpA with
OprPP was performed by Jason Gosschalk and used with permission.
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(Note: A portion of the writing in the following section is credited to Brendan
Amer, who performed the NMR experiments, and was used with permission.)

A. oris LcpA catalyzes phophotransfer. To further define the mechanism of surface
protein glycosylation by LcpA, we investigated its interactions with its GspA substrate
using solution NMR spectroscopy, which can detect transiently interacting proteins. 1H15N-HSQC

titration studies were performed with 15N-isotopically enriched rLcpA and 14N-

rGspA, a truncation of GspA lacking its predicted N-terminal signal peptide and Cterminal transmembrane region. A series of 1H–15N HSQC NMR spectra of 15N-rLcpA
with various amounts of the 14N-rGspA was acquired. The various spectra of the 15NrLcpA (up to1:4 15N-rLcpA-to-14N-rGspA ratio) titrations were partially resolved enabling
for line-shape, specifically peak-height analysis (Fig. 4-5A). Spectra of 15N-rLcpA and
14N-rGspA

at a 1:8 ratio respectively are completely broadened either due to sample

dilution or more likely spin-diffusion caused by complex formation. Unfortunately, due to
the low quality of the spectra, site-specific interactions or chemical-exchange equilibria
could not be estimated. However, analysis of 43 resolved peaks revealed that 4 of these
peaks with high signal-to-noise (approximately 20-fold over background), i.e., peaks 1,
10, 12, and 20 exhibited dose-dependent reduction in peak-height during the titration
experiment (Fig. 4-5B). This suggests that rLcpA and rGspA interact weakly in vitro.
Further refinement of this interaction will help define the LcpA-mediated mechanism of
glycopolymer transfer, and this data supports further studies of these interactions.

The structural evidence, pyrophosphatase activity, in vivo glycosylation, and
enzyme-substrate interaction above are consistent with the phosphotransfer activity of
LCP enzymes that have previously been shown to mediate WTA synthesis (44); WTA is
linked to the N-acetyl-muramic acid component of the cell wall via a phosphodiester
linkage (39,126). To examine if A. oris LcpA possesses phosphotransfer activity, we
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employed an in vitro phosphotransfer assay in which the recombinant enzyme rLcpA
was mixed with FPP and GspA proteins. After 24 h incubation at 30oC, protein samples
were analyzed by 2-D gel electrophoresis followed by immunoblotting with α-GspA.
Because deletion of lcpA results in the accumulation of several GspALMM species (Fig. 45C), we surmised that the GspALMM proteins are a substrate of LcpA. To facilitate
purification of GspALMM in A. oris, we engineered a GspA protein with its CWSS replaced
by a His-tag and the recombinant protein was expressed in the ∆lcpA mutant; GspALMM
proteins were purified from the culture medium by affinity chromatography. As compared
to the recombinant protein rGspA, which was used in Fig. 4-5A, the GspALMM proteins
migrated between the 25-kDa and 37-kDa markers (Fig. 4-5C). The identity of these
GspA proteins was also confirmed by mass spectrometry. If the GspALMM proteins are
substrates of LcpA, addition of LcpA and FPP should lead to phosphate modifications of
GspA (Fig. 4-5D), hence increasing acidity due to the negatively charged phosphate
group. As shown in Fig 5E, in the presence of the wild-type LcpA enzyme, two new
spots migrating between the 25-kDa and 37-kDa markers and towards the acidic pI were
detected as compared to samples treated with the inactive enzyme LcpAR149A.

To test if phosphate modification of GspALMM occurs via a phosphodiester bond
the LcpA + FPP + GspALMM samples were treated with hydrofluoric acid (HF), which
hydrolyzes phosphodiester bonds as previously demonstrated in Staphylococcus aureus
with an LCP enzyme (48) prior to 2D-gel electrophoresis and immunoblotting. Indeed,
HF treatment resulted in abrogation of phosphate modification (Fig. 4-5E; HF panels).
Altogether the results support the notion that LcpA is a phosphotransferase and that
GspALMM is a bona fide substrate for LcpA catalyzed-glycosylation.
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Figure 4-5: LcpA interacts with GspA in solution and catalyzes phosphotransfer.
(A) Presented is the full 1H-15N-HSQC of 250 µM 15N-recombinant LcpA with inset
showing representative data of overlaid 1H-15N-HSQC titration spectra displaying two
isolated peaks with high signal-to-noise. Red spectra 1:0 molar equivalents of 15N-rLcpA
to 14N-rGspA. Orange, Yellow, Green, and Blue represent 1:0.5, 1:1, 1:2, and 1:4
spectra, respectively. Peak 9 is an example, which does not exhibit a dose-dependent
decrease in peak height upon adding rGspA, and Peak 20 is shown as an example,
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which does exhibit drastic effects on peak height. (B) Normalized plot of peak intensity of
selected residues from titration experiment with high signal-to-noise. Intensity data was
normalized to 1:0 titration peak intensities. (C) Recombinant GspA (rGspA) and GspALMM
were purified affinity chromatography from E. coli and A. oris lysates, respectively, and
analyzed by SDS-PAGE and Coomassie staining. (D) Presented is a simplified
schematic for in vitro phosphotransfer. (E) The phosphotransfer reaction contained 12
µM of GspALMM, 4 µM of LcpA (WT or R149A) and 50 µM of FPP in 20 mM Tris-HCl (pH
8.0). After 72 h incubation at 30°C, protein samples were treated with hydrofluoric acid
(HF) or mock-treated prior to 2D-electrophoresis followed by immunoblotting with antiGspA antibodies. Insets with increased contrast were shown for boxed regions. NMR
analysis was performed by Brendan Amer and used with permission.
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Discussion
Members of the LCP protein family studied to date have been shown to attach
glycopolymers to peptidoglycan (120,121) with many demonstrated to possess
pyrophosphatase and phosphotransferase activities (44,47,97,127,128). LCP enzymes
are characterized as the terminal enzyme, which catalyzes the linkage of glycopolymers
to the muramic acid component of the peptidoglycan via a phosphodiester bond from a
prenyl pyrophosphate glycan donor (122,129). None of these enzymes, however, are
involved in glycosylation of cell wall anchored proteins. We present here experimental
evidence that A. oris LcpA – capable of catalyzing hydrolysis of diphosphate bonds and
phosphotransfer – glycosylates the cell wall anchored protein GspA prior to attachment
to peptidoglycan, a process that is facilitated by the housekeeping sortase SrtA (50).

Crystallization studies authenticate LcpA as a member of the LCP protein family,
revealing that LcpA is structurally related to B. subtilis TagT, a previously crystalized
LCP that mediates the linkage of WTAs to peptidoglycan (46). Both enzymes have a
similar hydrophobic tunnel lined with arginine residues (R149 and R266 in A. oris LcpA),
a conserved feature of LCP enzymes that is necessary for interaction with glycan donor
substrates. Consistent with this, alanine-substitution of the catalytic R149 residue
abrogates pyrophosphatase and phosphotransferase activities and glycosylation of
GspA. Unlike B. subtilis TagT, A. oris LcpA does not attach glycopolymers to
peptidoglycan, as a GspA mutant lacking the CWS still contains glycans (50). This raises
an intriguing question as to where glycopolymers are attached to GspA. While the
biochemical nature of the glycans and locations of the glycosylation sites remain to be
elucidated, the results presented in our previous publication (50) and Fig. 4-5 suggest
that an intermediate form of GspA, GspALMM, may serve as a substrate of LcpA. It is
interesting to note that A. oris harbors four LCP homologs, but only LcpA is involved in
GspA glycosylation (Fig. 4-1). Because lcpC is an essential gene and a conditional
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deletion mutant is not available, this does not exclude the possibility that LcpC may
modify GspA, leading formation of GspALMM. Future experiments will address this issue.

Intriguingly, the presence of a hydrophobic tunnel in the LcpA and TagT
structures as mentioned above suggests that the enzymes use a pyrophosphate-lipid
linked glycan donor. To gain insight into how this substrate bound, we used the structure
of the TagT enzyme bound to all cis octaprenyl‐pyrophosphate (opr‐PP) (PDB 4DE9) to
model the opr-PP:rLcpA complex. This was achieved by superimposing the protein
coordinates as well as the coordinates of the phosphate proximal to the glycan strand in
the structure of TagT and the active site phosphate atom present in the structure of
rLcpA. The model suggests rLcpA catalyzes a phosphotransfer reaction in which the
pyrophosphate linkage joining the lipid to the sugar molecule is broken, presumably as a
result of nucleophilic attack by an oxygen or nitrogen atom present an amino acid
sidechain within the GspA protein. As a result, the proximal phosphate and glycan are
transferred to GspA. In this reaction, R149 may stabilize the phosphate leaving group,
whereas R266 may favorable interact with the trigonal bipyramidal intermediate that
likely forms during catalysis. The process is thermodynamically favorable, as breakage
of the phosphoanhydride linkage in the substrate releases more free energy than is
required to attach a sugar molecule to the protein (the Gibbs standard free energy for
phosphoanhydride breakage in the substrate is ~-7.3 kcal/mol, whereas only ~3.3
kcal/mol is required to form the phosphodiester bond that joins the sugar to the protein).
The complexity of the glycans has prohibited our ability to determine the exact identity of
our glycans species, although this is a subject of current work.

Unlike other LCP proteins studied to date, A. oris LcpA possesses a distinct
feature, which appears to be commonly present in the actinobacterial LCP enzymes, i.e.,
a disulfide bond. Given disulfide bond formation is critical for oxidative folding of
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exported proteins in Actinobacteria (130), a process that is catalyzed by a pair of thioldisulfide oxidoreductase enzymes MdbA/VKOR in A. oris (62), we hypothesized that the
disulfide bond formed between C179 and C365 is essential for post-translocational
folding of LcpA. This is evident by the fact that mutations that abrogate the disulfide
bond C179-C365 severely affects stability of LcpA, whereas deletion of VKOR
significantly reduces LcpA stability (Fig. 4-3). Altogether, we propose that as the LcpA
precursor emerges from the Sec machine, it is folded by the MdbA/VKOR enzymes and
inserted into the membrane by the membrane protein insertase YidC. Separately, the
membrane-bound GspA is also transported by the Sec and further modified by an
unknown mechanism resulting in an intermediate form named GspALMM. LcpA catalyzes
the attachment of an unknown glycan chain to GspALMM, which is then anchored to the
bacterial peptidoglycan by the housekeeping sortase SrtA (Fig. 4-6). Given the
conservation of LCP and GspA proteins, this glycosylation pathway may be conserved in
Actinobacteria.
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Figure 4-6: Proposed model of LcpA-mediated glycosylation of the cell wallanchored protein GspA. A. oris LcpA is proposed to catalyze the linkage of unknown
glycopolymers to GspA, which is then anchored to the bacterial cell wall by the
housekeeping sortase SrtA. The oxidoreductase enzymes MdbA/VKOR is thought to
catalyze oxidative folding of LcpA (see text for details).
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CHAPTER V
Mapping the Molecular Domain in CafA Responsible
for Interkingdom Adherence
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Introduction
Bacterial adherence is an early and important step during infection and is mediated by
adhesins that define tissue tropism and interspecies interactions (131). Many Grampositive pathogens elaborate covalently linked sortase-catalyzed polymers with an
adhesive tip pilin to mediate this step in the infection (18,25,71,73,84). Sortases are a
broad class of transpeptidase enzymes that catalyze pilus polymerization and cell wall
anchoring of surface proteins. Actinomyces oris strain MG1 has become a model
organism to study the biogenesis of sortase-catalyzed pili (21). A. oris produces two
distinct pilus structures called type 1 and type 2 pili. Both types of pili confer distinct
adherence abilities to A. oris that are necessary to fulfill the role as a primary colonizer of
the oral biofilm (21). The role of A. oris as a primary colonizer is exemplified by studies
that show its early and specific colonization and localization at the biofilm base
(9,16,132).
Type 1 pili mediate bacterial adherence to the conditioned enamel of the tooth
via interactions with proline-rich proteins (18), whereas type 2 pili are involved in
coaggregation with oral streptococci and adherence to host cells (79,113). Therefore,
using pili, A. oris attaches to the tooth surface and enables further biofilm development
via the recruitment of bacteria, which cannot otherwise adhere to the substratum (2,133).
Accumulation of dental plaque can lead to dental diseases such as dental caries and
periodontitis that are considerable health burdens on a global scale (13). Ultimately,
accretion requires specific molecular interactions that serve as the basis for the
spatiotemporal development of the oral biofilm and is dependent on primary colonizers
providing the initial site of attachment for subsequent biofilm maturation (2,5). Following
attachment and microcolony formation by primary colonizers, coaggregation between
bacterial species can occur which serves to enhance bacterial attachment and mature
the biofilm (2). A. oris strain MG1 and S. oralis strain 34 are well-defined coaggregation
partners. Their interaction which can be monitored in by simply combining the two
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species in a defined buffer and observing the supernatant clearing and aggregate
formation (134). In this interaction, S. oralis provides a defined receptor polysaccharide
(RPS) with a terminal D-Gal-β-(1-3)-GalNac. A. oris provides the specific adhesin for this
interaction. It has been known that this interaction required type 2 pili from A. oris
(33,79). However, the specific adhesin remained unidentified until more recently when
coaggregation factor A (cafA) was identified in A. oris as required for this specific
interspecies interaction (25). The CafA adhesin is particularly interesting because unlike
other pilus-associated proteins that genetically cluster with the cognate pilin specific
sortase, cafA is located distant from SrtC2, which is required for its incorporation into
type 2 pili. Type 2 pili were also shown to be important for sialidase-dependent binding
of epithelial cells, however, CafA was not identified as the specific adhesin in this case
(17). Sialic acid normally conceals the TF antigen, which has a terminal residue of DGal-β-(1-3)-GalNac that bears similarity to the RPS from So34.
CafA hijacks the FimA backbone pilus to form a distinct CafA-FimA type 2 pilus
(25). On average, pilin tip proteins are larger compared to the respective backbone pilins
and have a multidomain structure including separable stalk and adherence domains.
Pilus tip proteins often serve as the functional adhesin for pili (71,135). This property,
combined with the fact that pili are accessible to immune cells and chemical modifiers,
makes pili and particularly adhesins good targets for anti-adhesive strategies (135,136).
Our past characterization of pilus components and pilus-related functions utilized
the lab strain A. oris MG1, however, a collection of clinical isolates taken from various
mouth sites has previously been characterized by the Cisar laboratory with serological
methods. Actinomyces have undergone major reclassification based on 16s rRNA and
multi-locus sequence typing of several housekeeping genes, and we refer to the
reclassified species designation rather than the serological description, and retain the
original serological strain nomenclature (137,138).
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Here I report the study of the molecular basis of CafA interkingdom adherence.
We first find that A. oris MG1 has the ability to adhere to human gingival fibroblasts
(HGF-1), and this interaction depends on CafA. We then utilized a clinical isolate screen
for the presence of CafA polymers and concurrence with So34 coaggregation. From this
screen we identified a single clinical isolate, A. oris strain N11A12, that displays CafA
polymers, but does not coaggregate with So34. Based on characterization and
sequencing of CafA from this isolate, we identified the specific amino acids responsible
for coaggregation with So34.
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Results
CafA binds a receptor that is conserved between oral streptococci and human
fibroblasts. Previous work in Actinomyces demonstrated the necessity of
sialidase/neuraminidase treatment to enhance epithelial cell binding (17,139). To
determine if A. oris MG1 binding to human cells was CafA dependent, we infected
human gingival fibroblasts (HGF-1) with A. oris. We found that wild-type adherence
increases about a hundred-fold (2-log difference) when the HGF-1 cells are treated with
sialidase prior to infection. A. oris ∆cafA binds HGF-1 at the level of MG1 without
sialidase and does not exhibit increased adherence after sialidase pretreatment (Fig. 51A). This indicates that sialidase treatment of HGF-1 uncovers a receptor that is
normally blocked by sialic acid, and that A. oris binding to the receptor is dependent
upon CafA. In human cells, sialic acid often caps the TF antigen, which has a terminal
Gal--(1-3)-GalNac (135). Actinomyes spp. possess and express a sialidase gene,
nanH, and a sialidase transporter, nanT, which are significantly upregulated in
Actinomyces naeslundii isolated specifically from root caries (140).
Coaggregation is mediated by an adhesin from one species and the coordinating
receptor of another. Moreover, prior work demonstrated the interaction between S. oralis
strain 34 and A. oris MG1 was determined to be mediated by a Gal--(1-3)-GalNac
moiety on So34, also called coaggregation group 3 (141). CafA was recently identified
as the specific adhesin necessary for binding So34 (25). We confirmed that the
coaggregation phenotype relies on the presence of CafA in A. oris MG1 (Fig. 5-1B).
Although, these results suggest that CafA is an interkingdom adhesin that utilizes D-Gal-(1-3)-GalNac as a receptor on both oral streptococci and human cells.
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Figure 5-1: CafA adheres to receptor polysaccharides present on HGF-1 and oral
streptococci. (A) HGF-1 adherence by A. oris MG1 or the isogenic deletion strain ∆cafA
in the presence (+) or absence (-) of sialidase treatment by direct measurement of
colony forming units per milliliter (cfu/mL). Student’s two-tailed, unpaired T-test; *** Pvalue < 0.0001. Input values are comparable (MOI ~ 200) as determined by
measurement of cfu/mL. (B) Coaggregation phenotype of A. oris MG1, ∆cafA, and the
CafA complement strain (∆cafA pCafA) with the RPS-positive S. oralis strain 34 (So34)
and RPS-negative strain S. oralis OC1 (SoC1).
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Actinomyces clinical isolates have differential coaggregation phenotypes and
CafA expression. We utilized coaggregation with So34 as a measure of the presence of
binding to the RPS on oral streptococci which is recognized by the species adhesin CafA
from A. oris MG1 (25). We wanted to determine whether Actinomyces clinical isolates
had differential phenotypes and whether we could identify at least one of which
displayed polymeric CafA, but did not coaggregate with So34. We first performed a
coaggregation assay of 23 clinical isolates (Table 5-1). Then we examined the cell wall
fractions of each isolate for the presence of polymeric CafA (Table 5-1). This screen
identified different coaggregation groups as previously reported (142,143). The majority
of the strains displaying polymeric CafA coaggregated with So34, as expected from our
results with the lab strain MG1. We also identified some isolates which bind both So34
and SoOC1, but exhibited either monomeric CafA or absence of CafA. Therefore, this
interaction may not necessarily be CafA dependent, because CafA requires
polymerization by FimA to be functional (25). Additionally, we found a monomeric CafA
with no So34 binding. Our most interesting finding, however, was that isolate 9, which
corresponds to A. oris strain N11A12, does not coaggregate with So34, despite
elaborating CafA polymers. This is considerably different from the other isolates that we
screened where polymeric CafA is obligatorily associated with So34 coaggregation. We
characterized this isolate to ensure that the coaggregation defect was not due to
significant changes of pilus structure or expression.
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Table 5-1: Coaggregation and CafA polymerization phenotypes of Actinomyces
clinical isolates.

Number

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22

Species

A. oris
A. oris
A. naeslundii
A. naeslundii
A. naeslundii
A. oris
A. oris
A. oris
A. oris
A. oris
A. oris
A. oris
A. oris
A. oris
A. oris
A. oris
A. oris
Non-serotypeable
Non-serotypeable
Non-serotypeable
A. johnsonii
A. johnsonii

(a)Isogenic derivative

Strain

MG1
∆cafA(a)
N28B15
N34A24
N35B3
N11A16
N12A2B
ATCC 49339
N11A12
ATCC 27044
N33A2B
N37B13
N34A23
N28B1
N29A27
N32A8
N37B9
N38B10
N33A3
N34A14
PK1259
ATCC 49338

Coaggregation with(b)
So34

OC1

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

+
+
+
+
-

CafA

p(c)
-(d)
m(e)
m
p
p
p
p
p
m
p
p
p
p
p
p
m
p
p
p

of MG1

(b)Positive

and negative signs indicate presence and absence of coaggregation,
respectively.
(c)CafA
(d)No

polymers

CafA signal

(e)CafA

monomer
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Characterization the clinical isolate A. oris strain N11A12. The coaggregation
deficient phenotype and display of CafA polymers of A. oris N11A12 prompted us to
further characterize this isolate. First, we repeated the coaggregation result outside of
the screening context and found that indeed coaggregation of this isolate with So34 was
defective (Fig. 5-2A).
We wanted to ensure that this isolate was not dissimilar to MG1 in monospecies
biofilm formation, which is mediated by FimA, the major pilin subunit of the type 2 pili
(84). To do this we utilized an in vitro biofilm assay and assessed them qualitatively and
quantitatively. Our lab strain MG1 and N11A12 are stained robustly by the crystal violet
and are not significantly different in their ability to form a monospecies biofilms. In
contrast, ∆fimA is defective in biofilm formation under the same conditions (Fig. 5-2B).
Next, we quantified the amount of FimA and CafA on the surface of MG1 and
N11A12 using whole-cell ELISA. We found that CafA was not significantly different
between the lab strain and the clinical isolate (Fig. 5-2C). We do note that FimA level is
increased significantly in N11A12 compared to MG1 (Fig. 5-2D). We concluded from
these data that lack of expression of type 2 pilus structural components was not the
cause of the coaggregation defect. However, to be functional, CafA must be polymer
associated (25). We previously detected the polymer through the screening process, but
wanted to ensure the presence of CafA polymers in the media and wall fraction of
N11A12 were similar to MG1 (Fig. 5-2E). We also detected FimA polymers in N11A12
which were similar to MG1 in the media and cell wall fraction, which we expected due to
the necessity of FimA polymers for monospecies biofilm formation (Fig. 5-2F). Also of
note, the size of the CafA and FimA monomer was very similar between MG1 and
N11A12. Additionally, we tested whether we could visualize CafA at the pilus tip by
immunogold labeling and electron microscopy, as we saw in our MG1 control, and was
well above nonspecific binding from ∆cafA (Fig. 5-2G & 5-2H). Indeed, in A. oris
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N11A12, CafA was present on pili and extended away from the cells (Fig. 5-2I).
Collectively, these data indicated that the coaggregation deficient phenotype of A. oris
strain N11A12 was not due to reduced expression or polymerization of CafA containing
pili.
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Figure 5-2: Characterization of type 2 pili and pilus-related functions in
Actinomyces oris strain N11A12. (A) Coaggregation assay with A. oris and S. oralis
cells suspended in coaggregation buffer in a 1:1 ratio. (B) In vitro biofilm assay of A. oris
MG1, ∆fimA, and N11A12. Biofilms were grown statistically in HIB + 1% sucrose for 48
h. Planktonic cells were washed away and the remaining biofilm was detected with
crystal violet. Crystal violet was released with EtOH and quantified at A580nm. The values
shown are the average of three independent replicates that were each run in triplicate,
and error bars represent standard error of the mean (SEM). Statistical analysis was
performed using an unpaired, two-tailed Student’s t-test. (C & D) Whole cell ELISA with
of A. oris MG1 and A. oris N11A12 with (C) α-CafA and (D) α -FimA antibodies. Data
shown from three independent replicates and all replicates were performed in
quadruplicate. Error bars represent SEM, and statistical analysis using unpaired, twotailed Student’s t-test. Designation ns refers to p >0.05, and *** p = 0.0001. This data
was generated by Alexis Bradford and used with permission. (E & F) Western blot
analysis of supernatant (S) and cell wall (W) fractions using (E) α-CafA and (F) α -FimA
antibodies. (G - I) IEM performed with (G) MG1, (H) ∆cafA (parental strain MG1) and (I)
N11A12 using an α-CafA primary antibody and 18-nm gold particles conjugated to the
secondary antibody. Scale bar represents 0.2 µM.
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Identification of specific residues that are critical for CafA adherence through
comparison with the CafA sequence from A. oris N11A12. We reasoned that
because the coaggregation defect did not appear to be due to differences in type 2 pilus
expression or structure, we could compare the primary amino acid sequence of CafA
from MG1 to that of N11A12 to find potential residues necessary for adherence. CafA
was present outside of the N11A12 cells and anchored to both pili and the cell wall, we
reasoned that any changes occurring in the signal peptide or cell wall sorting signal
domains were not significant for the adherence function. CafA from the lab strain MG1
and the clinical isolate N11A12 are 95.98% identical at the amino acid level, and we did
not detect any major insertions or deletions. By multiple sequence alignment we
identified 36 non-synonymous mutations. Eleven of the substitutions retained strong
conservation (e.g. Ser to Thr), and eight substitutions maintained weakly similar
properties, based on the Gonnet PAM 250 matrix. To begin to narrow down which
nonsynonymous mutations were meaningful, we sequenced cafA from two additional A.
oris isolates, which display the MG1 coaggregation and polymerization phenotypes,
N11A16 and N32A8. We compared changes in MG1, N11A16, and N32A8 to those in
N11A12 to identify changes in these strains that overlapped and thus could not be
implicated in the loss of CafA binding function. We were able to eliminate all but three
major changes found in the N-terminal domain. The remaining suspect substitutions
were K111M, R123H and Y145R (Fig. 5-3A). These amino acid changes were present in
the N-terminal portion of the protein that was previously purified and used to block
coaggregation (25). Additionally, amino acid changes occurring in basic amino acids
were of particular interest to us because previous reports of E. coli adhesins indicated
that Lys and Arg residues are involved in glycan receptor binding (135,144). Tyr has also
been implicated in glycan binding (135). To determine whether basic amino acids may
be involved in CafA binding, we first reacted MG1 and ∆cafA cells with sulfosuccinimidyl6-[biotin-amido]hexanoate which reacts with free amine groups found in Lys and Arg
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residues only on the cell surface. Sulfosuccinimidyl-6-[biotin-amido]hexanoate can
effectively block interaction with glycan receptors (144). We utilized binary qualitative
coaggregation to determine the effect of the chemical on coaggregation efficiency. We
determined that exposing A. oris MG1 to sulfosuccinimidyl-6-[biotin-amido]hexanoate
reduces coaggregation to ∆cafA levels (Fig. 5-3B).
Due to the fact that sulfosuccinimidyl-6-[biotin-amido]hexanoate could abrogate
coaggregation, we introduced the changes that occurred in K111 and R123 residues of
N11A12 CafA into the MG1 CafA by site-directed mutagenesis. These three
substitutions were introduced singly into pCafAMG1 by site-directed mutagenesis. I also
included the Y145 substitution, because it was substituted in N11A12 compared to the
other strains, and Tyr has been demonstrated to bind glycan moieties previously. Then, I
used these strains to test whether these residues were indeed necessary for
coaggregation with So34. All three mutant strains were defective in coaggregation with
RPS-positive, So34 (Fig. 5-3C).
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Figure 5-3: Analysis of nonsynonymous mutations between CafA from MG1 and
N11A12 identifies residues necessary for coaggregation. (A) Schematic with the
variable sequences between A. oris strains MG1, N11A16, N32A8 and N11A12 for
amino acids in the adherence domain. Sequencing was performed by Anh Dinh and
used with permission. (B) Coaggregation assay of MG1 and ∆cafA with So34 performed
in the absence (-) or presence (+) of sulfo-NHS-LC-biotin. (C) Coaggregation assay
carried out using So34 and A. oris and derived strains encoding CafAMG1 site-directed
mutants K111M, R123H and Y145R.
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Discussion
The oral biofilm is a polymicrobial community of bacterial species that relies on
hierarchical interactions with host surfaces and bacterial species. These interactions are
dictated by a sequential addition of new species to the biofilm based on their molecular
properties and can be defined by their temporal association, such as primary, bridging
and secondary colonizing species (2). They can also be defined by their pathogenic
potential, being inflammophilic, accessory pathogens compatible with inflammation or
completely incompatible with inflammation. These classifications have an underlying
molecular mechanism dictating temporal, spatial and inflammatory compatibility. Here,
we have defined molecular mechanisms and interactions associated with a primary
colonizer and accessory pathogen compatible with inflammation (12).
A. oris is well defined as a primary colonizer (2,9). Using type 1 pili to bind the
tooth surface and type 2 pili to mediate bacterial coaggregation and contact with host
cells which is dependent on either sialidase or inflammation to uncover the host cell
receptor (18,25). A. oris encodes a sialidase gene, nanH, and a transporter nanT which
is upregulated in the caries biofilm (140). Upregulation of nanH and nanT could promote
uncovering of the receptor for A. oris binding when the local concentration of the enzyme
increases, if the bacterium is below the surface of the gum. Additionally, chronically
inflamed cells often reveal the TF antigen due to dysregulation of sialiac acid production
(135). Bifunctional receptor binding may promote a pathogenic phenotype such that
upon recruitment of inflammophilic pathobionts to the biofilm, the resulting inflammation
would reveal the TF antigen. This would support a role for A. oris as a compatible
accessory pathogen, where it could maintain a subgingival biofilm (12,135).
The Actinomyces clinical isolate screen revealed differential phenotypes for the
presence and display of CafA It also reinforced research that demonstrated Actinomyces
species participate in different coaggregation groups (141). An interesting finding that
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came from this work is the presence of monomeric CafA proteins in only certain strains,
for example the only monomeric CafA in A. oris is from strain N37B13 (Table 5-1). This
isolate displays a predictable negative coaggregation phenotype, as it was previously
demonstrated that CafA needs to be polymerized by FimA to mediate coaggregation
(25). Therefore, this strain may provide clues about how CafA initially evolved to hijack
the type 2 pilus.
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CHAPTER VI
Exploring the Role of the Twin-Arginine Residues
in the CafA Signal Peptide
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Introduction
Pili are assembled on the exoplasmic membrane, and therefore the subunits must be
translocated prior to their assembly. General protein secretion in bacteria is mediated
either by the general secretion pathway (Sec) or twin-arginine translocon (Tat). The
major difference between Sec and Tat is that substrates of Sec are translocated as
unfolded polypeptides, whereas Tat transports only fully-folded proteins (54).
The current model for the process of polymerization begins when the pilin
precursors are translocated through the general secretory pathway (Sec) by an Nterminal signal peptide. The precursor is folded after secretion and retained in the
membrane by a C-terminal domain called the cell wall sorting signal (CWS) (40,62). The
CWS is required to covalently attach the tip protein to the incoming backbone pilin and
the backbone pilins to each other. In addition to the aforementioned CWS requirements
for sortase interaction, an additional sequence element, the triple glycine (TG) motif
GGxG or GGxA, is only found in proteins that interact with pilin-specific sortases. The
TG motif overlaps with the LPxTG motif in the pilin subunits of many organisms and was
shown to be critical for pilus assembly in Lactobacillus rhamnosus GG (145).
In some organisms the polymerization process requires the presence of a tip
protein, but the molecular details surrounding this process have not been elucidated
(18,25,146). In A. oris, the tip proteins FimQ, FimB and CafA are indeed required for
initiating the polymerization of the major pilin subunits (18,25). Interestingly, all of the
pilus initiation proteins, CafA, FimB and FimQ, have a putative Tat signal peptide,
suggesting that the tip proteins may use the twin arginine translocase (Tat). Moreover,
the conservation among them provides evidence that it may be important for initiating
pilus assembly. However, to date, all sortase substrates are known to utilize the general
secretion pathway for their secretion (40).
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The consensus sequence used to discriminate Tat from Sec signal peptides is
(S/T)RRxFLK. Primarily, this sequence information can be directly applied to identifying
E. coli Tat substrates, but Tat signal peptides from other organisms have demonstrated
tolerance for conservative mutations in this motif (103). The presence of a twin arginine
motif in signal peptide of the pilin precursors suggested the use of the Tat pathway,
although it was unclear if these proteins are secreted through the Tat pathway. In this
study, I investigated whether the CafA signal peptide was sufficient to mediate Tat
transport.
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Results
The CafA protein sequence contains three potential twin arginine residues within the
signal peptide where a putative signal peptidase cleavage site is predicted to be
between A56 and V57 (Fig. 6-1A). The presence of these residues suggested that CafA
may be secreted by the Tat pathway (56). In addition to the twin arginine residues, two
of the potential signals have a leucine reside at position +2, which has been shown to be
important an important residue for Tat translocation (147). To determine whether any of
these twin arginine motifs are important for CafA secretion, I created a variant that lacks
the cell wall sorting signal (CWS) and included a hexa-histidine tag at the C-terminus so
that the mutant protein is secreted into the supernatant rather than polymerized or cell
wall anchored (Fig. 6-1A). To substitute the potential arginine residues to alanine I used
site-directed mutagenesis (Fig. 6-1A). I confirmed that these constructs are expressed at
levels comparable to cafA containing a wild-type signal peptide using qRT-PCR of cafA
(Fig. 6-1B). The culture supernatants were concentrated and subjected to Western
blotting with an antibody against the C-terminal His-tag to measure CafA secretion and
levels. The RR1 and RR3 CafA signal peptide variants secrete CafA at levels similar to
the wild-type signal peptide. Only the RR2 mutation resulted in the lack of CafA
secretion (Fig. 6-1C). These results suggested that residues R11 and R12 are critical for
CafA secretion, and secretion may indeed require the Tat pathway. Because the RR2
variant was not secreted, I expected the protein to accumulate in the cytoplasmic
fractionation. However, I was unable to detect a significant signal in any fraction for the
RR2 mutant, which may indicate that reduced secretion was due to low protein
production or stability (Fig. 6-1D).
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Figure 6-1: Mutation of Arg 11 and Arg 12 to Ala abrogates CafA secretion and
destabilizes CafA. (A) Schematic of full-length CafA indicating the signal peptide (SP)
and cell wall sorting signal (CWS), and substitutions made in CafA variants RR1, RR2,
and RR3. The pCafA∆cws-H6 variant lacks the CWS and contains a hexa-histidine tag at
the C-terminus (blue rectangle). The SP is wild-type (WT) or mutated to Ala as indicated
in RR1, RR2 and RR3. (B) Western blot analysis of the supernatant fraction from A. oris
∆cafA strain expressing WT CafA, no CafA (-), or variants of CafA RR1, RR2, or RR3
reacted with an α-His monoclonal antibody conjugated to HRP. (C) Quantitative PCR
data expressed as a fold change calculated using the 2-∆∆G method and normalized to
the 16s rRNA. (D) Cell fractionation for supernatant (S), cell wall (W), membrane (M)
and cytoplasmic (C) fractions subjected to Western blot with an α-His monoclonal
antibody conjugated to HRP.
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To overcome both the protein stability challenge and determine whether the
signal peptide could indeed target the polypeptide for secretion through the Tat system,
we utilized heterologous Tat-dependent protein fusions. I chose two established
reporters to assess twin-arginine translocation, agarase and green fluorescent protein
(GFP) (103,148).
As a proxy for Tat transport, I first used the agarase secretion reporter. Agarase
is a natural actinobacterial Tat substrate in Streptomyces violaceoruber. Agarase activity
is Tat-dependent and is easily measurable using an agar clearance assay (102). This
assay has been previously used to assess whether heterologous signal peptides are
directed for transport by Tat (103). We began by investigating whether agarase with the
native S. violaceoruber signal peptide was functional when expressed in A. oris. The
promoter from A. oris EF-Tu (ana_0022) was used to drive expression of the agarase
encoding gene dagA (pDagASv). I grew A. oris pEV or A. oris pDagASv over 48 h as a
spot on a nutrient rich agar. The plates were then stained with Lugol’s reagent to visually
assess agar degradation. A distinct zone of clearance around the colonies demonstrated
that agarase is produced, exported, and functional in A. oris under our conditions and
that A. oris has no native agarase activity (Fig. 6-2A, dagASv versus EV). As a control for
Sec-mediated secretion, we fused the sequence encoding the FimA signal peptide to
dagA (Fig. 6-2A, fimASP-dagA) (62). To test whether CafA can secrete a functional
agarase, I fused the sequence encoding the CafA WT signal peptide to the DagA
sequence (Fig. 6-2A, cafASP-dagA). The results of the agarase fusion suggested that
CafA is not secreted by the Tat machine, as no zone of clearance is apparent in the
strain expressing the cafASP-dagA fusion. I wanted to confirm these results with a
secondary reporter protein assay.
For the GFP fluorescence Tat exclusive reporter assay, I used fluorescence to
measure secretion in a folded state. GFP can be targeted to the Sec pathway, and
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secreted in an unfolded state, but does not maintain complete fluorescence after
translocation. In contrast, when folded GFP is targeted to the Tat system, the secreted
protein fluoresces (148,149). Therefore, GFP translocation and fluorescence can be
assessed to determine the folding state during translocation. Additionally, I expected
GFP to be more stable in the cytoplasm making it possible to assess the localization of a
signal peptide fusion protein. There were no studies the identified Tat substrates in A.
oris. Therefore, I utilized the signal peptide from S. violaceoruber DagA as a positive
control, since I found that it is sufficient to mediate Tat transport when expressed in A.
oris (Fig. 6-2A) (103). I first employed a kinetic assay to measure fluorescence in the
supernatant over time. This assay determined that only dagASP-gfp had a detectable
signal above the gfpSP- background (Fig.6-2B). I then assayed the fraction of
fluorescence in the supernatant versus the whole cell to ensure that the proteins were
indeed being produced after 6 hours of growth. When the DagA signal peptide was
fused to GFP 94% of the fluorescent signal was in the supernatant compared to the
cytoplasmic GFP control in which fluorescence is primarily localized to the whole cell
fraction (Fig. 6-2C). When the CafA signal peptide was fused to GFP this construct
phenocopied the FimA signal peptide fusion, suggesting that Tat does not play a role in
secreting CafA (Fig. 6-2C).
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Figure 6-2: Evaluation of Tat-dependent reporter protein fusions. (A)
Representative images of A. oris CW1 colony grown on solid media overnight with
pCWu10-empty vector control (EV), pCWu10 expressing the DagA ORF from S.
violaceoruber (pDagASv) as a Tat control, pCWu10 expressing the FimA signal peptide
translationally fused to DagA lacking a signal peptide (pFimASP-DagA) as a Sec control,
or pCWu10 expressing the CafA signal peptide translationally fused to DagA lacking a
signal peptide (pCafASP-DagA). (B) Measurement of fluorescence intensity in the
supernatant over time of strains containing pCWu10 expressing the GFP with no signal
peptide (pGFPSP-), pCWu10 expressing the FimA signal peptide translationally fused to
GFP (pFimASP) as a Sec control, pCWu10 expressing the DagA signal peptide
translationally fused to GFP (pDagASP) or pCWu10 expressing the CafA signal peptide
translationally fused to GFP (pCafASP). (C) Measurement of fluorescence intensity from
the supernatant (SN) or whole cell (WC) fraction from normalized cultures in B grown to
midlog phase measured in triplicate and repeated in three independent experiments.
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Both of the established Tat-dependent reporter assays revealed that the CafA
signal peptide is likely not utilizing the Tat pathway for secretion. Although, the RR2
mutant was defective for secretion, it was unstably and poorly expressed. To test this, I
mutated the arginine residues to glutamine. Glutamine maintains a similar
hydrophobicity and size as arginine, but is not positively charged and is also not
sufficient to mediate Tat transport (Fig. 6-3A) (150,151). However, the mutation of RR2
to QQ was sufficient to restore translocation of CafA (Fig. 6-3B).
I next sought to determine the role of the CafA signal peptide since it was not
used for Tat secretion. I used fluorescence microscopy to visualize the GFP alone or
fused to CafA, FimA, and DagA signal peptides. The CafA signal peptide GFP fusion
presented an interesting phenotype. Unlike the gfp control, the cafASP-gfp had punctate
localization at the poles and septum (Fig. 6-3C). There are two major possibilities
directing this localization, 1) the CafA signal peptide mediates specific localization of the
fluorescent protein, or 2) the CafA signal peptide drives the fusion protein into insoluble
aggregates.
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Figure 6-3: Requirement of bulky hydrophobic residues for protein stability and
examination of GFP expressing strains by fluorescence microscopy. (A) Schematic
of full-length CafA indicating the signal peptide (SP) and cell wall sorting signal (CWS).
The pCafA∆cws-H6 variant lacks the CWS and contains a hexa-histidine tag at the Cterminus (blue rectangle). The SP is wild-type (WT), mutated to Ala as indicated in RR2
or Gln as indicated in QQ2. (B) Western blot analysis of the supernatant fraction from A.
oris ∆cafA strains harboring an empty vector (-), expressing wild-type CafA signal
peptide, RR2, or QQ2 signal peptide variants reacted with an α-His monoclonal antibody
conjugated to HRP. (C) Fluorescence micrographs of strains expressing GFP signal
peptide reporter fusion proteins from 6-2C. The scale bar represents 0.5 µM.
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To further investigate whether Tat was playing a role in pilus formation, I decided to
delete components of the Tat machine. During the course of attempting to delete tatA
and tatC genes individually and together, I found that it was not possible to recover a tat
mutant strains. Deletions in A. oris are made by first cloning the upstream and
downstream regions of the gene of interest into a knockout vector carrying an antibiotic
resistance cassette (93). The knockout vector replicates in E. coli, but is non-replicative
in A. oris. Therefore, it must integrate into the A. oris to confer the resistance phenotype.
The knockout vector also carries a gene, which is used for negative selection, galK. The
galK gene encodes galactose kinase and can phosphorylate galactose or 2deoxygalactose (2-DG). Phosphorylation of these sugar molecules retains the sugar
within the cell, and in the case of 2-DG, this is lethal. Depending on the orientation of the
first integration event (crossover), the outcome of the second crossover, which serves to
eliminate the plasmid from the chromosome, should have a 50% chance of recovering
the wild-type and 50% chance of recovering the mutant strain, if no deleterious effects
are associated with the deletion. However, we were unable to recover tatA, tatC or tatAC
deletions.
Next we constructed a conditional mutant to examine the effects of the loss of the
twin arginine translocon, where the gene of interest is under the control of a tet-inducible
promoter and a theophylline-responsive riboswitch. Since there is a small colony
phenotype compared to wild-type in the absence of inducer for the tatC conditional
mutant. By electron microscopy, the tatC conditional mutant strain appeared to have an
increase in cell shearing compared to the wild-type (Fig. 6-4A and 6-4B), but piliation did
not appear to be affected.
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Figure 6-4: Analysis of the tatC conditional mutant by electron microscopy. The
tatC conditional mutant was grown to midlog phase in the presence (A) or absence (B)
of inducers. The cells were then immobilized on nickel grids and stained with 1% uranyl
acetate prior to viewing with an electron microscope. Scale bar represents 0.5 µm.
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Discussion
This study determined that the Tat machinery is likely not responsible for transport of
CafA. However, my findings suggest that the CafA signal peptide contributes in novel
ways to CafA maturation. The CafA signal peptide has 56 amino acids and is therefore
much longer than an average signal peptide. A study, which examined signal peptide
variety, found that Gram-positive signal peptides are an average of 30 amino acids in
length with only 4.5% of signal peptides having greater than 40 amino acids. In addition,
the majority having a positive net charge (52). When compared to the established
actinobacterial Tat signal peptide from S. violaceoruber DagA, the CafA signal peptide
has twice as many positively charged residues per sequence length.
The arginine residues R11 and R12 are likely required for stabilizing the CafA
protein, because I was unable to detect CafA in the cytoplasmic fraction when I mutated
these to alanine (A), but when I mutated these residues to glutamine (Q), which should
abolish translocation if it was Tat mediated, I was able to functionally restore
translocation (Fig. 6-3B). When the cafASP-gfp reporter was visualized with fluorescence
microscopy, it displayed punctate localization at the cell poles and cell septum compared
to signal peptide lacking control reporter (Fig. 6-3C). Therefore, rather than serving as a
Tat signal sequence, this signal peptide may serve to localize CafA at distinct sites in the
membrane, which are also known to be where nascent peptidoglycan is deposited in
actinobacteria (65). Additionally, CafA has 12 cysteines, which potentially form six
disulfide bonds. It has been demonstrated in actinobacteria that disulfide bond
containing proteins are folded on the exoplasmic face of the membrane by a protein
called MdbA, a process called oxidative folding. Oxidative folding requires proteins to be
in an unfolded state during secretion, which is not compatible with the Tat machine (63).
Following several attempts at deletion of the twin-arginine translocon (Tat), it
seems likely that Tat secretion machine is essential for cell viability. Although, we were
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able to construct an inducible mutant, the depletion is not robust enough to produce a
viability phenotype, even with a subset of the cells displaying a “shearing” phenotype. It
will be interesting in the future to determine the cause of the Tat essentiality, as it is
typically non-essential.
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CHAPTER VII
Perspectives and Future Implications
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A Model for Bacterial Type I Signal Peptidases
A. oris expresses two distinct bacterial type I signal peptidases (SPases), LepB1 and
LepB2. Using FimA as a model substrate I have shown that LepB2 demonstrates
specificity for pilin proteins. Deletion of lepB2 dramatically reduces pilus assembly and
affects pilus-related phenotypes, such as biofilm formation. Conversely, LepB1 and
LepB2 can both act on a separate substrate, GspA (80). Having only two enzymes and a
semi-defined substrate repertoire makes the A. oris system ideal to study type I SPase
enzymes and to address some of the remaining questions in the field. Firstly, how do
SPases select specific substrates? This is especially intriguing when the SPase
enzymes are not temporally separated and I have shown that lepB1 and lepB2 are
expressed independently during logarithmic growth. Are the specificity determinants
present in the signal peptides, the SPase itself, or do both contribute? Finally, lepB1 and
lepB2 are the only traditional SPase enzymes present in the A. oris genome, but these
genes are not essential for cell viability and loss of both produces ragged termini in the
secreted substrates. So, does an uncharacterized secretion stress pathway exist in A.
oris?
Specificity of bacterial type I signal peptidases
The signal peptides of the pilin proteins do not differ significantly from the signal
peptide of GspA. In fact, in bacteria most signal peptides do not exhibit sequence
conservation aside from small neutral amino acids at positions P-1, P-3, and a helixbreaking residue in the P-6 position that are required for cleavage of all type I SPase
substrates (53). Additionally, LepB1 and LepB2 exhibit high similarity at the amino acid
level with the exception that LepB1 has an extended C-terminus, but these regions do
not correspond to specificity clefts present in the well-studied E. coli type I SPase (Fig.
7-1) (52). Gram-positive bacteria commonly encode numerous SPase I enzymes (60).
For example, B. subtilis encodes five SPases, and Streptomyces lividans encodes four
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of these proteins (109,152). Still, it remains unknown why multiple SPases exist in
Gram-positive bacteria. It has been shown that in S. lividans and A. oris SPases have
non-identical substrate preference suggesting that these SPases have specialized to
process different substrates (80,153). Moreover, what determines SPase substrate
specificity remains an open question. The A. oris dual SPase arrangement is useful for
addressing this question in particular, because there are definitive phenotypes
associated with the deletion of pilin specific LepB2 that do not affect cell viability.
A first step toward determining factors involved in signal peptidase specificity
would be to assess the secreted protein profile of a lepB2 deletion strain compared to
wild-type. Similar studies have been successfully performed in S. lividans, which also
has clear substrate specificity and no cell viability phenotype, but specificity profiling
focused on only a single substrate (108,153). A total secretome including proteins from
the supernatant, cell wall, and membrane could be analyzed in A. oris by performing
two-dimensional protein electrophoresis on the lepB2 deletion and comparing it to the
wild-type secretome. LepB2 specific processing could be confirmed similarly to the
methods that I described for FimA (80). I also found previously that surface exposure
decreases and the profile of pilus polymers changes in the absence of lepB2, and these
substrates can serve as a control. Identification of additional LepB2-specific substrates
could lead to a greater understanding about SPase I substrate selection. After analyzing
the secretome of LepB2 specific substrates, similarities between these proteins can be
analyzed to look for specificity determinants.
FimA serves as a fully characterized substrate of LepB2 and may be used to
determine whether features in the signal peptide or signal peptidase affect substrate
preference. A screen for biofilm formation could be performed with a large, random pool
of FimA signal peptide mutants. Transfer and sequencing of the biofilm defective
mutants would reveal sequences important for type I SPase processing. Also, analysis
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Figure 7-1: Sequence alignment of A. oris LepB1 and LepB2. Sequence alignment of
A. oris LepB1 and LepB2 was performed using CLUSTALW (112). The conserved SerLys catalytic dyad is highlighted in yellow. Asterisks (*) indicate fully conserved residues
and the colon (:) indicates conserved residue properties.
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of the SPase itself could be done by creating a chimeric LepB2 with the LepB1 Cterminal extension or eliminating the extension from LepB1. If these constructs modulate
FimA processing, further analysis can determine how the C-terminal extension affects
substrate selection.
FimA serves as a fully characterized substrate of LepB2, and may be used to
determine whether features in the signal peptide or signal peptidase affect substrate
preference. A screen for biofilm formation could be performed with a large, random pool
of FimA signal peptide mutants. Transfer and sequencing of the biofilm defective
mutants would reveal sequences important for type I SPase processing. Also, analysis
of the SPase itself could be done by creating a chimeric LepB2 with the LepB1 Cterminal extension, or eliminating the extension from LepB1. If these constructs
modulate FimA processing, further analysis can determine how the C-terminal extension
affects substrate selection.
Finally, analysis of the substrate pool and identifying factors contributing to
specificity may provide insight into the glycosylation pathway of GspA. Initially, lepB2
was isolated because it could suppress srtA essentiality (50). Surprisingly, it was found
that this was not due to a direct effect on the GspA substrate, but rather it modified the
glycosylation profile and accumulated low molecular mass GspA products in the
absence of lepB2 (80). Therefore, one of the substrates of LepB2 may be a glycosylation
enzyme, and absence of specific cleavage could decrease enzyme efficiency. This
enzyme may be part of the changed pool upon isolation of LepB2 specific substrates.
Secretion stress pathway
Deletion of both lepB1 and lepB2 from A. oris has a minor effect on growth
kinetics and produces a ragged N-terminus in the shared substrate GspA (Fig. 3-1C and
Table 3-1) (80). Endopeptidases, such as signal peptidases, cleave precisely generating
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a specific fragment. Ragged termini are typically indicative of an exopeptidase activity,
as they trim the polypeptide processively, but may also result from a new cleavage site
from an intramembrane protease (154). Thus our results suggest that there may be a
robust, yet undefined pathway for A. oris to cope with secretion stress resulting from a
block in signal peptide cleavage. A secretion stress system is present in S. aureus,
where the ayrRABC operon has been identified as encoding an alternative path that can
be utilized in the absence of a traditional type I SPase. Indeed, expression of ayrABC
results in imperfect cleavage sites like those identified for GspA. This operon was
identified under treatment with the antibiotic arylomycin that acts by inhibiting type I
SPase enzymes (155). Arylomycin works synergistically with β-lactam antibiotics on
methicillin-resistant S. aureus by specifically targeting and inhibiting SPase I SpsB
activity (156).
If arylomycin is effective against A. oris LepB1 and LepB2 and does not produce
a growth defect, it could be utilized to screen for synthetic lethal mutants against a
transposon library. By patch plating onto plates with and without arylomycin, those
mutants that cannot grow in the presence of arylomycin would be selected for
sequencing. The identified genes could be analyzed, especially for their effect on
secreted proteins and whether their gene products exhibit proteolytic activity.
A New Paradigm for an LCP Enzyme
LcpA is a unique LCP enzyme because of its ability to modify the protein substrate GspA
with glycopolymers. This is not a conserved feature for all LCP enzymes, even those
present in A. oris, and in fact it has never been demonstrated before in any organism
(Fig. 4-1B) (81). My work has uncovered that LcpA acts as a phosphotransferase to
transfer a lipid-linked glycopolymer to GspA, and this represents the terminal step of
GspA glycosylation. The composition of the glycan transferred to GspA remains
completely unknown. Beyond that, what genes are involved in synthesizing these
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glycopolymers? It is important to address these questions in A. oris, because although
the activity of LcpA is functionally similar to other LCP enzymes, how recognition of the
acceptor substrate occurs prior to glycan transfer is not well understood. Characterizing
LcpA could uncover information applicable to all LCP enzyme acceptor selection.
LcpA selects novel acceptor substrate
LcpA seems to be distantly phylogenetically related to currently characterized
enzymes and even other enzymes encoded by A. oris (Fig. 7-2). The closest match to
LcpA by BLAST search appears to be an LCP enzyme encoded by the actinobacterium
Geodermatophilus obscurus. It may be interesting to determine whether the G. obscurus
LCP enzyme can be expressed heterologously in A. oris and whether an LcpA-GspA like
relationship exists in this species. LcpA may serve as the founding member of a new
type of LCP, but until additional members are identified it will be difficult to elucidate the
evolutionary changes that drove LcpA to select a new acceptor.
Regardless of whether LcpA is the sole member of its group, it is still unknown
how LcpA specifically selects the GspA protein acceptor. The catalytic core of the LcpA
enzyme exhibits high structural similarity with other enzymes, especially B. subtilis TagT
(Fig. 4-2). Many of the biochemical activities first described for wall teichoic LCP
enzymes are also conserved in LcpA and require similar molecular features. Therefore,
it is likely that the substrate selection domain exists outside of this conserved region.
Remodeling these domains or targeting mutagenesis to the sequences encoding
structurally dissimilar regions may reveal how GspA is selected by LcpA. Additionally,
the antibodies and pyrophosphatase assay presented in this thesis can be adapted to
ensure LcpA stability and activity remain functional in the mutant constructs. GspA
glycosylation can be simply assessed by immunoblotting for GspA glycosylation.
GspA glycan profile
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Another unknown feature regarding GspA is the glycopolymer identity, which
unfortunately makes it difficult to recreate an accurate substrate for in vitro reactions or
to understand the function of the glycosylated GspA. Lectin-based profiling is a
technique that would be useful to begin characterizing the composition of the glycan
present on the GspA low and high molecular mass moieties. Lectins are proteins that
recognize sugars with high specificity. This methodology has been useful and successful
in other applications, and high throughput arrays have been adapted from the low
throughput technology (157). Many lectins are available conjugated to either a
fluorescent or peroxidase molecule to facilitate their application. To narrow down which
glycans are present in GspA LMM and HMM, a technique called lectin-blotting could be
accomplished using these labeled lectins (158). Purified GspA LMM or HMM separated
by SDS PAGE would be reacted with a series of lectins that each recognize a unique
sugar moiety. This information would then be incorporated to further analyze the glycan
using enzymatic digestion and mass spectrometry techniques (159).
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Figure 7-2: Phylogenetic analysis of LCP proteins. The tree was rooted with the HDdomain containing protein from Thermotoga maritima (WP_004082198) and constructed
by the mega6 program. Numbers at nodes represent percentage levels of bootstrap
support based on the unweighted pair group method with arithmetic mean of 1000
resampled datasets.
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GspA glycan synthetic pathway
My study highlights several similarities between A. oris LcpA and WTA synthesis.
However, no genes upstream of LcpA involved in the synthesis of GspA glycopolymers
have been identified. We may exploit knowledge and tools derived from the well-studied
S. aureus wall teichoic acid synthesis pathway, which begins in the cytoplasm and is
mediated by tar genes to determine whether a parallel pathway exists in A. oris.
Chemical inhibitors and their targets have been identified that affect synthesis of the
teichoic acid in S. aureus (160,161). Early steps in the pathway, initiated by tarO and
tarA, are non-essential for cell viability. tarO transfers a GlcNAc molecule onto Und, and
tarA transfers a ManNAc sugar onto the GlcNAc-Und precursor. The GlcNAc-ManNAc
priming sugars on undecaprenol (Und) is a product that can be recycled if the process is
stalled. The first step, transfer of GlcNAc by tarO, can be inhibited with sub-lethal
concentrations of tunicamycin (160). The remaining steps responsible for construction of
the teichoic acid using the tarOA Und-GlcNAc-ManNAc platform, involve genes
tarBFLGH. These downstream genes are essential for cell viability likely because the
Und can no longer be recycled at this stage, which would stall other cellular processes.
The tarBFL genes are responsible for adding glycerol-3-phosphate and ribitol-5phosphate to synthesize the variable length lipid-linked teichoic acid. The completed
teichoic acid is subsequently flipped across the membrane by tarGH gene products. A
second WTA inhibitor compound called targosil targets tarG inhibiting teichoic acid
flipping and subsequently eliminating its incorporation into the cell wall, where it
accumulates at the cytoplasmic side of the membrane (161). Potentially, the WTA
inhibitors tunicamycin and targosil can be used in A. oris to assess whether these
inhibitors affect GspA glycosylation mirroring WTA synthesis. If the molecules can inhibit
GspA glycosylation, they can be used to identify genes in the synthesis pathway, which
will likely have similar characteristics to the S. aureus genes.
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Many of the features that I have uncovered regarding LcpA structure and activity
are similar to those described for LCP proteins with a role in WTA synthesis. Therefore,
future work should focus on how the differences displayed by LcpA drive its novel
substrate selection. However, given that WTA synthesis is well-understood and there are
more tools available to study it, using the properties from this pathway as a starting point
will undoubtedly contribute to determining the overall GspA glycosylation pathway.

Interkingdom Adhesin with a Pivotal Role in Oral Biofilm Formation
CafA is a pilus-associated adhesin that binds a receptor polysaccharide (RPS) present
on some oral streptococci, and I found that it can also mediate adherence to human cells
under certain conditions (25). A. oris is primary colonizer of the oral biofilm and CafA
plays a major role the niche selection. What structural characteristics confer CafA the
ability to bind RPS and why does binding require extension on the pilus protein? The
tertiary structure of CafA is unknown, in part because CafA cannot be stably purified
from a traditional E. coli over-expression system. I utilized an alternative approach of
comparison of CafA amino acid sequences from a strain that displays a negative
coaggregation phenotype. With this approach, I identified a several residues important
for coaggregation. Are these residues present in a conserved domain and do they
similarly affect human cell binding? Finally, does the signal peptide of CafA contribute to
localization and pilus assembly in a way which has not yet been explored?
Structural identity of CafA
A CafA structure would be useful to better understand the structural components
required for RPS binding as well as assigning the identified residues necessary for CafA
adherence. There have been technical challenges purifying CafA from an E. coli
overexpression system likely because of the large size and number of cysteines that
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potentially form disulfide bonds. To simplify purification of full length CafA, I developed a
native expression system; although it is plagued by low yield, it produces pure, stable,
full-length protein (Fig. 7-3). A structure of CafA would also be informative about the
nature of the disulfide bond scheme and how these contribute to maintaining the
structural integrity of this protein.
CafA strain N11A12 glycan specificity
It is unknown whether the changes present in CafA from A. oris strain N11A12
result in reduced binding capacity for all glycans, or whether the mutations confer a new
glycan specificity. To test this, a glycan spot array using purified proteins from A. oris
MG1 and A. oris N11A12 could be employed to determine whether a new specificity of
N11A12 exists. This would be analogous to E. coli, where the chaperone-usher tip pilins
FimH and FmlH have a similar structure but exhibit an entirely different glycan binding
specificity. FmlH adheres only under inflammatory conditions, when the sialic acid
production is downregulated and the receptor is uncovered (135). There could be a
similar mechanism for CafA, where the N11A12 has a new target.
CafA signal peptide localization and pilus assembly
From the experiments outlined here, the CafA signal peptide does not seem to
have the capacity to translocate proteins through the Tat pathway. However, using
fluorescence microscopy, it is clear that when GFP is fused to the CafA signal peptide it
displays a punctate localization. In contrast, the Tat-targeted GFP and the GFP alone
have a diffuse localization. Therefore, the CafA signal peptide may be localizing GFP to
areas of nascent peptidoglycan synthesis, where under native conditions CafA would
initiate synthesis of a CafA-containing type 2 pilus. However, these puncta could also be
a result of protein aggregation in the cell. To distinguish between these possibilities, the
cafASP-gfp strain could be fractioned into the soluble and insoluble fractions,
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Figure 7-3. Purification of CafA from A. oris supernatant. (A) Coomassie blue
stained total supernatant (SN), cleared supernatant (CS), flow-through (FT), wash (W),
eluate (E) and pre-concentration, post-desalt (DST) fractions from A. oris expressing
pCafA∆CWS-Hisx6 separated by SDS-PAGE. (B) Immunoblot of the supernatant (SN)
fraction with an α-His monoclonal antibody.
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immunblotted with an α-GFP antibody, and compared to the signal from the gfp only
expressing strain. If cafASP-gfp is soluble, it would suggest genuine localization by the
CafA signal peptide. The cafASP-gfp could then be immunoprecipitated by α-GFP to
determine whether there are additional factors, like chaperones, involved in localizing
this protein to the midcell and poles. Then, confirmed with immunofluorescence of the
native CafA protein.

Essentiality of the Twin-Arginine Translocon
From the work presented here, the twin-arginine translocon (Tat) appears to be essential
in A. oris. Essentiality of the twin arginine transporter has been demonstrated previously
in the actinobacterium Mycobacterium tuberculosis, but was never linked to a particular
substrate (162). By bioinformatic analysis of secreted proteins, there are 43 potential Tat
substrates in A. oris based on the presence of a signal peptide and a twin arginine motif
within the first 50 amino acids (Table 7-1). Which of these predicted substrates actually
requires the Tat machine for secretion? Appending the signal peptides to the agarase
reporter with those from proteins on the list may provide a better view about what
constitutes a Tat signal peptide in A. oris, especially because the CafA signal peptide is
a predicted to be a Tat signal peptide, yet failed to display Tat-dependency.
Of these potential Tat substrates, which contribute to the essentiality of the Tat
pathway in A. oris? The NADH dehydrogenase (ana_0411) was identified on this list
and has been demonstrated to be a bona fide Tat substrate and is a potential cause for
loss of aerobic growth in Corynebacterium glutamicum, but is not essential for viability
(163). Additionally, several subunits of the NADH dehydrogenase complex could be
deleted from A. oris in a previous study (125). Confirming which of the signal peptides
can indeed
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Table 7-1: Predicted Tat-dependent proteins in the A. oris genome. The A. oris MG1
proteome was searched for consecutive “RR” within first 50 amino acids, then filtered
through TatP to confirm Tat consensus and signal peptide cleavage site.
Annotation
OmpA/MotB
OmpA/MotB
OmpA/MotB
OmpA/MotB
Lipoprotein, putative
OmpA family
LPXTG-motif protein (FimB)
LPXTG-motif protein
Zn/Mn transport substrate binding protein
Oxidoreductase
Tannase
Glycosyl/glycerophosphate transferase teichoic acid
biosynthesis
Polysaccharide deacetylase
Peptidase, M23/M37 family
Hypothetical protein
NADH dehydrogenase
ABC-type multidrug transport, ATPase
Peptidylprolyl isomerase, FKBP type
Virulence factor MVIN family
Hypothetical protein
ABC-type Co/Fe siderophore transport
Von Willebrand factor, type A domain containing
Mannose-6-phosphate isomerase
Hypothetical protein
ABC-type proline/glycine betaine transport system
ABC-type multiple sugar transport system
Peptide/Ni transport system
Hydrolase, alpha/beta fold family
Multicopper oxidase, type 3
Lipoprotein
Hly-III family
Tat pathway signal sequence domain
Hypothetical protein
Polysaccharide deacetylase
Glycoside hydrolase
Membrane-fusion protein
Cobalamin/Fe siderophore transport system
CnaB domain containing (CafA)
Hypothetical protein
Usher-like protein precursor (FimQ)
Type 1 fimbrial major subunit (FimP)
Exo-alpha-sialidase
ABC-type cobalamin/Fe3+ siderophores transport
system

Los Alamos ID
ana_0003
ana_0004
ana_0005
ana_0008
ana_0009
ana_0013
ana_0023
ana_0196
ana_0218
ana_0238
ana_0255
ana_0303
ana_0318
ana_0332
ana_0387
ana_0411
ana_0458
ana_0589
ana_1001
ana_1354
ana_1460
ana_1486
ana_1537
ana_1540
ana_1633
ana_1639
ana_1692
ana_1727
ana_1755
ana_1762
ana_1803
ana_1831
ana_1864
ana_1914
ana_1967
ana_2031
ana_2051
ana_2235
ana_2283
ana_2509
ana_2510
ana_2709
ana_2758
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mediate Tat transport from the predictions using the agarase reporter would significantly
narrow down which of the proteins on the list may be responsible for Tat essentiality.
Together these considerations make it worth exploring the role of these gene products in
bacterial physiology, and the strict requirement for the machine may explain why
actinobacteria utilize the apparatus for export of critical products.

Final Remarks
Cell surface proteins and glycoconjugates have a significant impact on bacterial
physiology. My studies have addressed several aspects of the molecular assembly and
display of these proteins. Cell surface proteins require secretion prior to fulfilling their
function. I have found that a specific type I SPase is necessary for pilus polymerization,
and also applied tools to investigate Tat secretion in A. oris. I have found that in the
exoplasmic space, LcpA utilizes a conserved mechanism to mediate glycosylation of a
novel acceptor substrate GspA. Finally, I demonstrated that Actinomyces clinical isolates
exhibit differential CafA display and exploited these differences to identify key amino
acid changes that contribute to the binding of A. oris MG1 CafA.
Studies of the fascinating microbes in the oral communities continue to reveal
their importance in human health and disease. These works illuminate the complex
components necessary for A. oris to fulfill its function as primary colonizer of the oral
biofilm. These studies have also uncovered new tools and information, which is
applicable to principles of biofilm formation, interspecies interactions, glycoconjugate
formation, and bacterial pathogenesis.
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